HERBICIDAL ARYLCYCLOPENTENE CARBOXAMIDES

Abstract
The invention relates to compounds of formula (I), and their use as herbicides. In said formula, R1 to R8 represent groups such as hydrogen, halo-gen or organic groups such as alkyl, alkenyl, alkynyl, or alkoxy; W1 and W2 are —CR9R10—, —C(O)—, —O—, X is a bond or a divalent unit; Y is hydrogen, cyano, hydroxyl or a linear or cyclic organic group. The invention further refers to a composition comprising such compound and to the use thereof for controlling unwanted vegetation.
Description

The present invention relates to arylcyclopentene carboxamides and compositions comprising the same. The invention also relates to the use of the arylcyclopentene carboxamides or the corresponding compositions for controlling unwanted vegetation. Furthermore, the invention relates to methods of applying the arylcyclopentene carboxamides or the corresponding compositions.


For the purpose of controlling unwanted vegetation, especially in crops, there is an ongoing need for new herbicides that have high activity and selectivity together with a substantial lack of toxicity for humans and animals.


WO12130798, WO1404882, WO14048882, WO18228985, WO18228986, WO19034602, WO19145245, WO20114932, WO20114934 and WO20182723 describe 3-phenylisoxazoline-5-carboxamides and their use as herbicides.


The compounds of the prior art often suffer from insufficient herbicidal activity, in particular at low application rates, and/or unsatisfactory selectivity resulting in a low compatibility with crop plants.


Accordingly, it is an object of the present invention to provide compounds having a strong herbicidal activity, in particular even at low application rates, a sufficiently low toxicity for humans and animals and/or a high compatibility with crop plants. The arylcyclopentene carboxamides should also show a broad activity spectrum against a large number of different unwanted plants.


These and further objectives are achieved by the compounds of formula (I) defined below including their agriculturally acceptable salts, amides, esters or thioesters.


Accordingly, the present invention provides compounds of formula (I)




embedded image


wherein the substituents have the following meanings:

    • W1, W2 each independently —CR9R10—, —C(O)—, —O—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C3)-haloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-haloalkoxy;
    • R2 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R3 hydrogen, halogen, nitro, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, hydroxy-(C1-C3)-alkyl, (C3-C5)-cycloalkyl, (C3-C5)-halocycloalkyl, hydroxy-(C3-C5)-cycloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C1-C3)-alkoxycarbonyl, (C2-C3) alkenyl, (C2-C3)-haloalkenyl, (C2-C3) alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl;
    • R4 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R5 hydrogen, halogen, nitro, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, hydroxy-(C1-C3)-alkyl, (C3-C5)-cycloalkyl, (C3-C5)-halocycloalkyl, hydroxy-(C3-C5)-cycloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C1-C3)-alkoxycarbonyl, (C2-C3) alkenyl, (C2-C3)-haloalkenyl, (C2-C3) alkynyl, (C2-C3)haloalkynyl, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl;
    • R6 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R7 hydrogen, halogen, cyano, or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, cyano and (C1-C6)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl and (C3-C5)-cycloalkyl;
    • R9, R10 each independently hydrogen, halogen, cyano, or (C1-C6)-alkyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, and cyano; or R9 and R10 form, together with the carbon atom to which they are bound, a saturated, partially or fully unsaturated three to six-membered ring containing, in addition to this carbon atom, q carbon atoms and n oxygen atoms;
    • X a bond (X0) or a divalent unit from the group consisting of (X1), (X2), (X3), (X4), (X5), and (X6):




embedded image




    • R11-R16 each independently hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd, NRbCO2Re, Ra, or (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano, or (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C3-C6)-alkenyloxy, (C3-C6)-alkynyloxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl or (C1-C3)-alkylsulfonyl, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano and (C1-C2)-alkoxy;

    • Y hydrogen, cyano, hydroxyl, Z,
      • or
      • (C1-C12)-alkyl, (C3-C3)-cycloalkyl, (C2-C12)-alkenyl or (C2-C12)-alkynyl, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, ORd, Z, OZ, NHZ, S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe;

    • Z a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, Rb, Rc, Re and Rf, and where the sulfur atoms and carbon atoms bear n oxo groups;

    • Ra (C1-C6)-alkyl, (C3-C6)-cycloalkyl or phenyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxy, and (C1-C3)-alkoxy;

    • Rb hydrogen, (C1-C3)-alkoxy or Ra;

    • Rc fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa or (C1-C6)-alkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;

    • Rd hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C3-C6)-cycloalkyl-(C1-C3)-alkyl, phenyl-(C1-C3)-alkyl or (C2-C4)-alkynyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano, CO2Ra, CONRbRh, (C1-C2)-alkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, phenylthio, phenylsulfinyl, and phenylsulfonyl;

    • Re Rd;

    • Rf (C1-C3)-alkyl or (C1-C3)-alkoxy;

    • Rh hydrogen or (C1-C6)-alkyl, (C1-C2)-alkoxy, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano, CO2Ra and (C1-C2)-alkoxy;

    • m 0, 1, 2, 3, 4 or 5;

    • n 0, 1 or 2;

    • q 1, 2, 3, 4 or 5;

    • r 1, 2, 3, 4, 5 or 6;

    • including their agriculturally acceptable salts, amides, esters or thioesters, provided the compounds of formula (I) have a carboxyl group; except the compounds N-(1,1-Dimethylethyl)-2,3-dihydro-2-methyl-3-oxo-5-phenyl-2-furancarboxamide and N,N-dimethyl-3-phenyl-cyclopent-3-ene-1-carboxamide.





The present invention also provides formulations comprising at least one compound of formula (I) and auxiliaries customary for formulating crop protection agents.


The present invention also provides combinations comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C).


The present invention also provides the use of compounds of formula (I) as herbicides, i.e. for controlling undesired vegetation.


The present invention furthermore provides a method for controlling undesired vegetation where a herbicidal effective amount of at least one compound of formula (I) is allowed to act on plants, their seeds and/or their habitat.


If the compounds of formula (I), the herbicidal compounds B and/or the safeners C as described herein are capable of forming geometric isomers, for example E/Z isomers, it is possible to use both, the pure isomers and mixtures thereof, according to the invention.


If the compounds of formula (I), the herbicidal compounds B and/or the safeners C as described herein have one or more centres of chirality and, as a consequence, are present as enantiomers or diastereomers, it is possible to use both, the pure enantiomers and diastereomers and their mixtures, according to the invention.


If the compounds of formula (I), the herbicidal compounds B and/or the safeners C as described herein have ionizable functional groups, they can also be employed in the form of their agriculturally acceptable salts. Suitable are, in general, the salts of those cations and the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the activity of the active compounds.


Preferred cations are the ions of the alkali metals, preferably of lithium, sodium and potassium, of the alkaline earth metals, preferably of calcium and magnesium, and of the transition metals, preferably of manganese, copper, zinc and iron, further ammonium and substituted ammonium in which one to four hydrogen atoms are replaced by C1-C4-alkyl, hydroxy-C1-C4-alkyl, C1-C4-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkoxy-C1-C4-alkyl, phenyl or benzyl, preferably ammonium, methylammonium, isopropylammonium, dimethylammonium, diethylammonium, diisopropylammonium, trimethylammonium, triethylammonium, tris(isopropyl)ammonium, heptylammonium, dodecylammonium, tetradecylammonium, tetramethylammonium, tetraethylammonium, tetrabutylammonium, 2-hydroxyethylammonium (olamine salt), 2-(2-hydroxyeth-1-oxy)eth-1-ylammonium (diglycolamine salt), di(2-hydroxyeth-1-yl)ammonium (diolamine salt), tris(2-hydroxyethyl)ammonium (trolamine salt), tris(2-hydroxypropyl)ammonium, benzyltrimethylammonium, benzyltriethylammonium, N,N,N-trimethylethanolammonium (choline salt), furthermore phosphonium ions, sulfonium ions, preferably tri(C1-C4-alkyl)sulfonium, such as trimethylsulfonium, and sulfoxonium ions, preferably tri(C1-C4-alkyl)sulfoxonium, and finally the salts of polybasic amines such as N,N-bis-(3-aminopropyl)methylamine and diethylenetriamine.


Anions of useful acid addition salts are primarily chloride, bromide, fluoride, iodide, hydrogensulfate, methylsulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate and also the anions of C1-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate.


Compounds of formula (I), herbicidal compounds B and/or safeners C as described herein having a carboxyl group can be employed in the form of the acid, in the form of an agriculturally suitable salt as mentioned above or else in the form of an agriculturally acceptable derivative, for example as amides, such as mono- and di-C1-C6-alkylamides or arylamides, as esters, for example as allyl esters, propargyl esters, C1-C10-alkyl esters, alkoxyalkyl esters, tefuryl ((tetrahydrofuran-2-yl)methyl) esters and also as thioesters, for example as C1-C10-alkylthio esters. Preferred mono- and di-C1-C6-alkylamides are the methyl and the dimethylamides. Preferred arylamides are, for example, the anilides and the 2-chloroanilides. Preferred alkyl esters are, for example, the methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, mexyl (1-methylhexyl), meptyl (1-methylheptyl), heptyl, octyl or isooctyl (2-ethylhexyl) esters. Preferred C1-C4-alkoxy-C1-C4-alkyl esters are the straight-chain or branched C1-C4-alkoxy ethyl esters, for example the 2-methoxyethyl, 2-ethoxyethyl, 2-butoxyethyl (butotyl), 2-butoxypropyl or 3-butoxypropyl ester. An example of a straight-chain or branched C1-C10-alkylthio ester is the ethylthio ester.


The terms used for organic groups in the definition of the variables are, for example the expression “halogen”, collective terms which represent the individual members of these groups of organic units.


The prefix Cx-Cy denotes the number of possible carbon atoms in the particular case. All hydrocarbon chains can be straight-chain or branched.

    • halogen: fluorine, chlorine, bromine, or iodine, especially fluorine, chlorine or bromine; alkyl and the alkyl moieties of composite groups such as, for example, alkoxy, alkylamino,
    • alkoxycarbonyl: saturated straight-chain or branched hydrocarbon radicals having 1 to 10 carbon atoms, for example C1-C10-alkyl, such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl; heptyl, octyl, 2-ethylhexyl and positional isomers thereof; nonyl, decyl and positional isomers thereof;
    • haloalkyl: straight-chain or branched alkyl groups having 1 to 10 carbon atoms (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above. In one embodiment, the alkyl groups are substituted at least once or completely by a particular halogen atom, preferably fluorine, chlorine or bromine. In a further embodiment, the alkyl groups are partially or fully halogenated by different halogen atoms; in the case of mixed halogen substitutions, the combination of chlorine and fluorine is preferred. Particular preference is given to (C1-C3)-haloalkyl, more preferably (C1-C2)-haloalkyl, such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl or 1,1,1-trifluoroprop-2-yl;
    • alkenyl and also the alkenyl moieties in composite groups, such as alkenyloxy: unsaturated straight-chain or branched hydrocarbon radicals having 2 to 10 carbon atoms and one double bond in any position. According to the invention, it may be preferred to use small alkenyl groups, such as (C2-C4)-alkenyl; on the other hand, it may also be preferred to employ larger alkenyl groups, such as (C5-C3)-alkenyl. Examples of alkenyl groups are, for example, C2-C6-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl;
    • haloalkenyl: alkenyl groups as mentioned above which are partially or fully substituted by fluorine, chlorine, bromine and/or iodine, for example 2-chloroprop-2-en-1-yl, 3-chloroprop-2-en-1-yl, 2,3-dichloroprop-2-en-1-yl, 3,3-dichloroprop-2-en-1-yl, 2,3,3-trichloro-2-en-1-yl, 2,3-dichlorobut-2-en-1-yl, 2-bromoprop-2-en-1-yl, 3-bromoprop-2-en-1-yl, 2,3-dibromoprop-2-en-1-yl, 3,3-dibromoprop-2-en-1-yl, 2,3,3-tribromo-2-en-1-yl or 2,3-dibromobut-2-en-1-yl;
    • alkynyl and the alkynyl moieties in composite groups, such as alkynyloxy: straight-chain or branched hydrocarbon groups having 2 to 10 carbon atoms and one or two triple bonds in any position, for example C2-C6-alkynyl, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl and 1-ethyl-1-methyl-2-propynyl;
    • haloalkynyl: alkynyl groups as mentioned above which are partially or fully substituted by fluorine, chlorine, bromine and/or iodine, for example 1,1-difluoroprop-2-yn-1-yl, 3-chloroprop-2-yn-1-yl, 3-bromoprop-2-yn-1-yl, 3-iodoprop-2-yn-1-yl, 4-fluorobut-2-yn-1-yl, 4-chlorobut-2-yn-1-yl, 1,1-difluorobut-2-yn-1-yl, 4-iodobut-3-yn-1-yl, 5-fluoropent-3-yn-1-yl, 5-iodopent-4-yn-1-yl, 6-fluorohex-4-yn-1-yl or 6-iodohex-5-yn-1-yl;
    • cycloalkyl and also the cycloalkyl moieties in composite groups: mono- or bicyclic saturated hydrocarbon groups having 3 to 10, in particular 3 to 6, carbon ring members, for example C3-C6-cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl. Examples of bicyclic radicals comprise bicyclo[2.2.1]heptyl, bicyclo[3.1.1]heptyl, bicyclo[2.2.2]octyl and bicyclo[3.2.1]octyl. In this connection, optionally substituted C3-C3-cycloalkyl means a cycloalkyl radical having from 3 to 8 carbon atoms, in which at least one hydrogen atom, for example 1, 2, 3, 4 or 5 hydrogen atoms, is/are replaced by substituents which are inert under the conditions of the reaction. Examples of inert substituents are CN, C1-C6-alkyl, C1-C4-haloalkyl, C1-C6-alkoxy, C3-C6-cycloalkyl, and C1-C4-alkoxy-C1-C6-alkyl;
    • halocycloalkyl and the halocycloalkyl moieties in halocycloalkoxy, halocycloalkylcarbonyl and the like: monocyclic saturated hydrocarbon groups having 3 to 10 carbon ring members (as mentioned above) in which some or all of the hydrogen atoms may be replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine;
    • cycloalkoxy: cycloalkyl groups as mentioned above which are attached via an oxygen;
    • alkoxy and also the alkoxy moieties in composite groups, such as alkoxyalkyl: an alkyl group as defined above which is attached via an oxygen, preferably having 1 to 10, more preferably 2 to 6, carbon atoms. Examples are: methoxy, ethoxy, n-propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy or 1,1-dimethylethoxy, and also for example, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy or 1-ethyl-2-methylpropoxy;
    • haloalkoxy: alkoxy as defined above, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as described above under haloalkyl, in particular by fluorine, chlorine or bromine. Examples are OCH2F, OCHF2, OCF3, OCH2Cl, OCHCl2, OCCl3, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, OC2F5, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2—C2F5, OCF2—C2F5, 1-(CH2F)-2-fluoroethoxy, 1-(CH2Cl)-2-chloroethoxy, 1-(CH2Br)-2-bromoethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy; and also 5-fluoropentoxy, 5-chloropentoxy, 5-bromopentoxy, 5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy;
    • alkylthio: an alkyl group as defined above, which is attached via a sulfur atom preferably having 1 to 6, more preferably 1 to 3, carbon atoms.
    • alkylsulfinyl: an alkyl group as defined above, which is attached via S(O), preferably having 1 to 6, more preferably 1 to 3, carbon atoms.
    • alkysulfonyl: an alkyl group as defined above, which is attached via S(O)2, preferably having 1 to 6, more preferably 1 to 3, carbon atoms.
    • hydroxyl: OH group which is attached via an O atom;
    • cyano: CN group which is attached via an C atom;
    • nitro: NO2 group which is attached via an N atom.


The preferred embodiments of the invention mentioned herein below have to be understood as being preferred either independently from each other or in combination with one another.


According to particular embodiments of the invention, preference is given to those compounds of formula (I) wherein the variables, either independently of one another or in combination with one another, have the following meanings:


Preferred compounds according to the invention are compounds of formula (I), wherein W1 is —CR9R10—, —C(O)—, or —O—, preferably —CH2—, —C(O)—, or —O—. In particular, W1 is —O—.


Further preferred compounds according to the invention are compounds of formula (I), wherein W2 is —CR9R10— or —C(O)—. In particular WP is —CR9R10—. Very particular, W2 is —CH2—.


Further preferred compounds according to the invention are compounds of formula (I), wherein R1 is selected from the group consisting of hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C3)-haloalkyl, (C2-C3)-alkenyl, (C2-C3)-alkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl.


More preferred compounds according to the invention are compounds of formula (I), wherein R1 is selected from the group consisting of hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, and (C1-C3)-alkoxy-(C1-C3)-alkyl.


Also preferred compounds according to the invention are compounds of formula (I), wherein R1 is selected from the group consisting of hydrogen, methyl, and methoxymethyl.


In particular, R1 is hydrogen.


Further preferred compounds according to the invention are compounds of formula (I), wherein R2 is selected from the group consisting of hydrogen, halogen and (C1-C3)-alkyl.


Also preferred compounds according to the invention are compounds of formula (I), wherein R2 is selected from the group consisting of hydrogen, fluorine, chlorine and methyl.


In particular, R2 is hydrogen.


Further preferred compounds according to the invention are compounds of formula (I), wherein R3 is selected from the group consisting of hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy and (C1-C3)-haloalkoxy.


Also preferred compounds according to the invention are compounds of formula (I), wherein R3 is selected from the group consisting of hydrogen, halogen, methyl, ethyl, trifluoromethyl, methoxy and trifluoromethoxy.


In particular, R3 is hydrogen or halogen, very particular chlorine or fluorine.


Further preferred compounds according to the invention are compounds of formula (I), wherein R4 is selected from the group consisting of hydrogen and halogen.


Also preferred compounds according to the invention are compounds of formula (I), wherein R4 is selected from the group consisting of hydrogen, fluorine, chlorine and bromine.


In particular, R4 is hydrogen or hydrogen, fluorine or chlorine, very particular hydrogen.


Further preferred compounds according to the invention are compounds of formula (I), wherein R5 is selected from the group consisting of hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy and (C1-C3)-haloalkoxy.


Also preferred compounds according to the invention are compounds of formula (I), wherein R5 is selected from the group consisting of hydrogen, halogen, methyl, ethyl, trifluoromethyl, methoxy and trifluoromethoxy.


In particular, R5 is hydrogen or halogen, very particular chlorine or fluorine.


Further preferred compounds according to the invention are compounds of formula (I), wherein R6 is selected from the group consisting of hydrogen, halogen and (C1-C3)-alkyl.


Also preferred compounds according to the invention are compounds of formula (I), wherein R6 is selected from the group consisting of hydrogen, fluorine, chlorine and methyl.


In particular, R6 is hydrogen.


Further preferred compounds according to the invention are compounds of formula (I), wherein R7 is selected from the group consisting of (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C2-C3)-alkenyl, and (C1-C3)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, and (C1-C2)-alkoxy. In this context, m is preferably 0, 1, 2, or 3.


Also preferred compounds according to the invention are compounds of formula (I), wherein R7 is selected from the group consisting of (C1-C2)-alkyl, cyclopropyl, (C1-C2)-haloalkyl, (C2-C3)-alkenyl, and (C1-C2)-alkoxy.


In particular, R7 is methyl, ethyl, chloromethyl, trifluoromethyl, cyclopropyl, ethenyl, and methoxy, very particular methyl.


Further preferred compounds according to the invention are compounds of formula (I), wherein R8 is selected from the group consisting of hydrogen, halogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C2)-haloalkyl.


Also preferred compounds according to the invention are compounds of formula (I), wherein R8 is selected from the group consisting of hydrogen, halogen, (C1-C2)-alkyl, cyclopropyl, trifluoromethyl.


In particular, R8 is hydrogen, fluorine or chlorine, very particular hydrogen.


Further preferred compounds according to the invention are compounds of formula (I), wherein R9 and R10 each independently are selected from the group consisting of hydrogen, halogen, (C1-C3)-alkyl, and (C1-C3)-haloalkyl.


Further preferred compounds according to the invention are compounds of formula (I), wherein R9 and R10 each independently are selected from the group consisting of hydrogen, fluorine, chlorine, and methyl.


In particular, R9 and R10 are hydrogen.


In the compounds of formula (I), X is selected from the group consisting of a bond (X0) or a divalent unit from the group consisting of (X1), (X2), (X3), (X4), (X5) and (X6), wherein the orientation of (X1), (X2), (X3), (X4), (X5) and (X6) within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen, the right arrow representing the bond to the adjacent group Y.




embedded image


In a preferred embodiment (compounds of formula (I.X0)), X is a bond (X0):




embedded image


In another preferred embodiment (compounds of formula (I.X1)), X is (X1), wherein the orientation of (X1) within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen, the right arrow representing the bond to the adjacent group Y:




embedded image


In another preferred embodiment (compounds of formula (I.X2)), X is (X2), wherein the orientation of (X2) within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen, the right arrow representing the bond to the adjacent group Y:




embedded image


In another preferred embodiment (compounds of formula (I.X3)), X is (X3), wherein the orientation of (X3) within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen, the right arrow representing the bond to the adjacent group Y:




embedded image


In another preferred embodiment (compounds of formula (I.X4)), X is (X4), wherein the orientation of (X4) within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen, the right arrow representing the bond to the adjacent group Y:




embedded image


In another preferred embodiment (compounds of formula (I.X5)), X is (X5), wherein the orientation of (X5) within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen, the right arrow representing the bond to the adjacent group Y:




embedded image


In another preferred embodiment (compounds of formula (I.X6)), X is (X6), wherein the orientation of (X6) within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen, the right arrow representing the bond to the adjacent group Y:




embedded image


Further preferred compounds according to the invention are compounds of formula (I), wherein X is selected from the group consisting of a bond (X0) or a divalent unit from the group consisting of CH2, CH2CH2, CHCH3, CH2CH2CH2, CH(CH2CH3), CH(CH3)CH2, C(CH3)2, C(CH3)2CH2, C(iPr)CH3, CH(CH2iPr)CH2, CH2CH═CH, C(CH3)2C═C, CH(CF3)CH2, CH(CH3)CH2O, CH2CH2O, CH(cPr)CH2O, CH(CH2OCH3), CH(CH2CH2SCH3), CH(COOH), CH(COOCH3), CH(COOH)CH2, CH(COOCH3)CH2, CH2COH(CF3), CH(CONHCH3), CH(CONHCH3)CH2 and CH2CH2CONHCH2.


Further preferred compounds according to the invention are compounds of formula (I), wherein R11-R16 each independently is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd, or (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, each substituted by m radicals from the group consisting of fluorine, or (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C3-C6)-alkenyloxy, (C3-C6)-alkynyloxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, and (C1-C3)-alkylsulfonyl, each substituted by m radicals from the group consisting of fluorine.


Also preferred compounds according to the invention are compounds of formula (I), wherein R11-R16 each independently is selected from the group consisting of hydrogen, fluorine, chlorine, CO2Re, CONRbRd, or (C1-C6)-alkyl, substituted by m radicals from the group consisting of fluorine, or (C1-C6)-alkoxy, substituted by m radicals from the group consisting of fluorine.


In particular, R11-R16 each independently is selected from the group consisting of halogen, (C1-C6)-alkyl, (C1-C3)-alkoxy, and CO2Re.


Further preferred compounds according to the invention are compounds of formula (I), wherein Y is selected from the group consisting of hydrogen, cyano, hydroxyl, Z, or (C1-C12)-alkyl, (C3-C3)-cycloalkyl, (C2-C12)-alkenyl or (C2-C12)-alkynyl each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, Z, CO2Re, and CONRbRh.


Also preferred compounds according to the invention are compounds of formula (I), wherein Y is selected from the group consisting of hydrogen, cyano, hydroxyl, Z, or (C1-C12)-alkyl, and (C3-C3)-cycloalkyl, each substituted by m radicals from the group consisting of fluorine, CO2Re, and CONRbRh.


Also preferred compounds according to the invention are compounds of formula (I), wherein Y is selected from the group consisting of (C1-C12)-alkyl, (C3-C3)-cycloalkyl, (C2-C12)-alkenyl or (C2-C12)-alkynyl, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, ORd, Z, OZ, NHZ, S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe.


Also preferred compounds according to the invention are compounds of formula (I), wherein Y is selected from the group consisting of (C1-C12)-alkyl, (C3-C3)-cycloalkyl, (C2-C12)-alkenyl or (C2-C12)-alkynyl, each substituted by m radicals from the group consisting of fluorine and CO2Re.


In particular, Y is selected from the group consisting of Z, or (C1-C12)-alkyl and (C3-C3)-cycloalkyl, each substituted by m radicals from the group consisting of fluorine, (C1-C2)-alkoxy, CO2Re, CONRbRh, and CONReSO2Ra.


Very particular, Y is selected from the group consisting of Z, or (C1-C12)-alkyl and (C3-C8)-cycloalkyl, each substituted by m radicals from the group consisting of fluorine, (C1-C2)-alkoxy, CO2Re, and CONRbRh.


According to one preferred embodiment, Y is Z.


Preferred compounds according to the invention are compounds of formula (I), wherein Z is selected from the group consisting of three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic rings, except phenyl, which are formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which are substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf, and where the sulfur atoms and carbon atoms bear n oxo groups.


Representative examples for the three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic rings mentioned above, are the following structures:




embedded image


Preferred compounds according to the invention are compounds of formula (I), wherein Z is selected from the group consisting of four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic rings, except phenyl, which are formed from r carbon atoms and n oxygen atoms, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NOReRb, Rc, Re and Rf, and where carbon atoms bear n oxo groups.


Also preferred compounds according to the invention are compounds of formula (I), wherein Z is selected from the group consisting of four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic rings, except phenyl, which are formed from r carbon atoms and n oxygen atoms, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, Rb, Rc, Re and Rf, and where carbon atoms bear n oxo groups.


Also preferred compounds according to the invention are compounds of formula (I), wherein Z is selected from the group consisting of four-, five- or six-membered saturated or partly unsaturated rings, which are formed from r carbon atoms and n oxygen atoms, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf.


Also preferred compounds according to the invention are compounds of formula (I), wherein Z is selected from the group consisting of five-membered saturated or partly unsaturated rings, which are formed from 4 carbon atoms and 1 oxygen atom, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf.


Representative examples for the five-membered saturated or partly unsaturated rings, which are formed from 4 carbon atoms and 1 oxygen atom, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf mentioned above, are the following structures, the arrow indicating the bond to any of the mentioned substituents:




embedded image


Preferred examples for the five-membered saturated or partly unsaturated rings, which are formed from 4 carbon atoms and 1 oxygen atom, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf mentioned above, are the following structures, the arrow indicating the bond to any of the mentioned substituents, preferably to CO2Re:




embedded image


Also preferred compounds according to the invention are compounds of formula (I), wherein Z is selected from the group consisting of five-membered saturated or partly unsaturated rings, which are formed from 5 carbon atoms, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf.


Representative examples for the five-membered saturated or partly unsaturated rings, which are formed from 5 carbon atoms, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf mentioned above, are the following structures, the arrow indicating the bond to any of the mentioned substituents:




embedded image


Preferred examples for the five-membered saturated or partly unsaturated rings, which are formed from 5 carbon atoms, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf mentioned above, are the following structures, the arrow indicating the bond to any of the mentioned substituents, preferably to CO2Re:




embedded image


In particular, Z is selected from the group consisting of cyclobutyl, cyclopentyl, cyclopentenyl, and tetrahydrofuranyl, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf.


Very particular, Z is selected from the group consisting of cyclobutyl, cyclopentyl, cyclopentenyl, and tetrahydrofuranyl, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, Rb, Rc, Re and Rf.


Preferred examples Z.1 to Z.5, each substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf mentioned above, are the following structures, arrow (1), representing the binding site to X, arrows (2) and (3) indicating the bond to any of the mentioned substituents, in particular to CO2Re, CONRbRh, Rb, Rc, Re and Rf:




embedded image


Preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10—, or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, preferably hydrogen;
    • R2 hydrogen;
    • R3 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R4 hydrogen or fluorine, preferably hydrogen;
    • R5 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R6 hydrogen;
    • R7 fluorine, cyano, or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, cyano and (C1-C6)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, cyano, or (C1-C6)-alkyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, and cyano; or
    • R9 and R10 form, together with the carbon atom to which they are bound, a saturated, partially or fully unsaturated three to six-membered ring containing, in addition to this carbon atom, q carbon atoms and n oxygen atoms;
    • X a bond;
    • Y Z;
    • Z a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf, and where the sulfur atoms and carbon atoms bear n oxo groups;
    • Ra (C1-C6)-alkyl (C3-C6)-cycloalkyl or phenyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Rb hydrogen, (C1-C3)-alkoxy or Ra;
    • Rc fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa or (C1-C6)-alkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Re hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, phenyl-(C1-C3)-alkyl (C2-C4)-alkynyl or (C3-C6)-cycloalkyl-(C1-C3)-alkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Rf (C1-C3)-alkyl or (C1-C3)-alkoxy;
    • Rh hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • r 1, 2, 3, 4, 5 or 6;
    • n 0, 1 or 2;
    • m 0, 1, 2, 3, 4 or 5;
    • q 1, 2, 3, 4 or 5.


Further preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10—, or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, preferably hydrogen;
    • R2 hydrogen;
    • R3 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R4 hydrogen or fluorine, preferably hydrogen;
    • R5 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R6 hydrogen;
    • R7 fluorine, cyano, or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, cyano and (C1-C6)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, (C1-C3)-alkyl, or (C1-C3)-haloalkyl;
    • X a bond;
    • Y Z;
    • Z a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals from the group consisting of CO2Re, and where the sulfur atoms and carbon atoms bear n oxo groups;
    • Re hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C4)-alkenyl, phenyl-(C1-C3)-alkyl (C3-C4)-alkynyl or (C3-C6)-cycloalkyl-(C1-C3)-alkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • r 1, 2, 3, 4, 5 or 6;
    • n 0, 1 or 2;
    • m 0, 1, 2, 3, 4 or 5.


Further preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10—, or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, preferably hydrogen;
    • R2 hydrogen;
    • R3 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R4 hydrogen or fluorine, preferably hydrogen;
    • R5 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R6 hydrogen;
    • R7 fluorine, cyano, or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, cyano and (C1-C6)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, (C1-C3)-alkyl, or (C1-C3)-haloalkyl;
    • X a bond;
    • Y Z;
    • Z five-membered saturated, partly unsaturated, or fully unsaturated carbocycle, which is substituted by m radicals from the group consisting of CO2Re, CONRbRh, CONReSO2Ra, Rb, Rc, Re and Rf;
    • R1 (C1-C6)-alkyl, (C3-C6)-cycloalkyl or phenyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Rb hydrogen, (C1-C3)-alkoxy or Ra;
    • Rc fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa or (C1-C6)-alkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Re hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, phenyl-(C1-C3)-alkyl (C2-C4)-alkynyl or (C3-C6)-cycloalkyl-(C1-C3)-alkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Rf (C1-C3)-alkyl or (C1-C3)-alkoxy;
    • Rh hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • m 0, 1, 2 or 3.


Further preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10—, or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C3)-haloalkyl, (C2-C3)-alkenyl, (C2-C3)-alkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, preferably hydrogen, (C1-C3)-alkyl, or (C3-C4)-cycloalkyl, more preferably hydrogen;
    • R2 hydrogen;
    • R3 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R4 hydrogen or fluorine, preferably hydrogen;
    • R5 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R6 hydrogen;
    • R7 fluorine, cyano, or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, cyano and (C1-C6)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, (C1-C3)-alkyl, or (C1-C3)-haloalkyl;
    • X a bond;
    • Y Z;
    • Z five-membered saturated, partly unsaturated, or fully unsaturated carbocycle, which is substituted by m radicals from the group consisting of CO2Re and Rb;
    • Rb hydrogen or (C1-C6)-alkyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Re hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C4)-alkenyl, phenyl-(C1-C3)-alkyl (C3-C4)-alkynyl or (C3-C6)-cycloalkyl-(C1-C3)-alkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • m 0, 1, 2 or 3.


Further preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10— or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, preferably hydrogen;
    • R2 hydrogen;
    • R3 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R4 hydrogen or fluorine, preferably hydrogen;
    • R5 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R6 hydrogen;
    • R7 fluorine, cyano, or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, cyano and (C1-C6)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, (C1-C3)-alkyl, or (C1-C3)-haloalkyl;
    • X a bond;
    • Y (C1-C3)-alkyl, (C3-C3)-cycloalkyl, (C2-C3)-alkenyl or (C2-C3)-alkynyl, each substituted by m radicals from the group consisting of fluorine and CO2Re;
    • Re hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, phenyl-(C1-C3)-alkyl or (C2-C4)-alkynyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • m 0, 1, 2, or 3.


Further preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10— or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C3)-haloalkyl, (C2-C3)-alkenyl, (C2-C3)-alkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, preferably hydrogen, (C1-C3)-alkyl, or (C3-C4)-cycloalkyl, more preferably hydrogen;
    • R2 hydrogen;
    • R3 halogen, cyano, (C1-C3)-alkyl, preferably fluorine or chlorine;
    • R4 hydrogen or fluorine, preferably hydrogen;
    • R5 halogen, cyano, (C1-C3)-alkyl, preferably fluorine, or chlorine;
    • R6 hydrogen;
    • R7 fluorine, cyano, or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, cyano and (C1-C6)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, (C1-C3)-alkyl, or (C1-C3)-haloalkyl;
    • X a bond;
    • Y (C1-C3)-alkyl, (C3-C3)-cycloalkyl, (C2-C3)-alkenyl or (C2-C3)-alkynyl, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, ORd, Z, OZ, NHZ, S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe;
    • Z a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals from the group consisting of CO2Re, CONRbRh, Rb, Rc, Re and Rf, and where the sulfur atoms and carbon atoms bear n oxo groups;
    • Ra (C1-C6)-alkyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Rb hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Rc fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa or (C1-C6)-alkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Rd hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, phenyl-(C1-C3)-alkyl or (C2-C4)-alkynyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Re hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, phenyl-(C1-C3)-alkyl or (C2-C4)-alkynyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Rf (C1-C3)-alkyl or (C1-C3)-alkoxy;
    • Rh hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • r 1, 2, 3, 4, 5 or 6;
    • m 0, 1, 2 or 3;
    • n 0, 1 or 2.


Further preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10—, or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C3)-haloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-haloalkoxy;
    • R2 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R3 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C5)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R4 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R5 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C5)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R6 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R7 (C1-C2)-alkyl, cyclopropyl, (C1-C2)-haloalkyl, (C2-C3)-alkenyl, (C1-C2)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, (C1-C3)-alkyl, or (C1-C3)-haloalkyl;
    • X a bond (X0) or a divalent unit from the group consisting of (X1), (X2), (X3), (X4), (X5), and (X6):




embedded image




    • R11-R16 each independently hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd, Ra, or (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano, or (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano and (C1-C2)-alkoxy;

    • Y hydrogen, cyano, hydroxyl, Z,
      • or
      • (C1-C12)-alkyl, (C3-C3)-cycloalkyl, (C2-C12)-alkenyl or (C2-C12)-alkynyl each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, ORd, Z, OZ, NHZ, S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe;

    • Z a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals from the group consisting of CO2Re, CONRbRh, Rb, Rc, Re and Rf, and where the sulfur atoms and carbon atoms bear n oxo groups;

    • Ra (C1-C6)-alkyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;

    • Rb hydrogen or Ra;

    • Rc fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa or (C1-C6)-alkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;

    • Rd hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, phenyl-(C1-C3)-alkyl or (C2-C4)-alkynyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;

    • Re Rd;

    • Rf (C1-C3)-alkyl or (C1-C3)-alkoxy;

    • Rh hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;

    • m 0, 1, 2, 3, 4 or 5;

    • n 0, 1 or 2;

    • r 1, 2, 3, 4, 5 or 6.





Further preferred compounds of the present invention are compounds of formula (I), wherein

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10—, or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C3)-haloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-haloalkoxy;
    • R2 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R3 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C5)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R4 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R5 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C5)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R6 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R7 (C1-C2)-alkyl, cyclopropyl, (C1-C2)-haloalkyl, (C2-C3)-alkenyl, (C1-C2)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, (C1-C3)-alkyl, or (C1-C3)-haloalkyl;
    • X a bond;
    • Y Z, or (C1-C3)-alkyl, (C3-C3)-cycloalkyl, (C2-C3)-alkenyl or (C2-C3)-alkynyl, each substituted by m radicals from the group consisting of fluorine and CO2Re;
    • Z four to five-membered saturated or partly unsaturated ring which is formed from r carbon atoms, n oxygen atoms, and which is substituted by m radicals from the group consisting of CO2Re, CONRbRh, Rb, Rc, Re and Rf;
    • Ra (C1-C6)-alkyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Rb hydrogen, or (C1-C6)-alkyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Rc fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa or (C1-C6)-alkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Re hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, phenyl-(C1-C3)-alkyl or (C2-C4)-alkynyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Rf (C1-C3)-alkyl or (C1-C3)-alkoxy;
    • Rh hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • m 0, 1, 2, 3, 4 or 5;
    • n 0, 1 or 2;
    • r 1, 2, 3, 4, or 5.


Further preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10—, or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C3)-haloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-haloalkoxy;
    • R2 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R3 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C5)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R4 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R5 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C5)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R6 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R7 fluorine, cyano, or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, cyano and (C1-C6)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, (C1-C3)-alkyl, or (C1-C3)-haloalkyl;
    • X a bond;
    • Y Z;
    • Z four to five-membered saturated or partly unsaturated ring which is formed from r carbon atoms, n oxygen atoms, and which is substituted by m radicals from the group consisting of CO2Re, CONRbRh, Rb, Rc, Re and Rf;
    • Ra (C1-C6)-alkyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Rb hydrogen, or (C1-C6)-alkyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Rc fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa or (C1-C6)-alkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Re hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, phenyl-(C1-C3)-alkyl or (C2-C4)-alkynyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Rf (C1-C3)-alkyl or (C1-C3)-alkoxy;
    • Rh hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • m 0, 1, 2, 3, 4 or 5;
    • n 0, 1 or 2;
    • r 1, 2, 3, 4, or 5.


Further preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CR9R10—, —C(O)—, or —O—;
    • W2 —CR9R10—, or —C(O)—;
    • R1 hydrogen, (C1-C3)-alkyl, (C3-C4)-cycloalkyl, (C1-C3)-haloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-haloalkoxy;
    • R2 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R3 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C5)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R4 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R5 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-halocycloalkyl, (C1-C3)-haloalkoxy, (C2-C3)-haloalkenyl, (C2-C3)-haloalkynyl;
    • R6 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy;
    • R7 fluorine, cyano, or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-alkoxy, each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, cyano and (C1-C6)-alkoxy;
    • R8 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, preferably hydrogen;
    • R9, R10 each independently hydrogen, halogen, (C1-C3)-alkyl, or (C1-C3)-haloalkyl;
    • X a bond;
    • Y (C1-C12)-alkyl, (C3-C3)-cycloalkyl, (C2-C12)-alkenyl or (C2-C12)-alkynyl each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, ORd, Z, OZ, NHZ, S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe;
    • Z a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals from the group consisting of CO2Re, CONRbRh, Rb, Rc, Re and Rf, and where the sulfur atoms and carbon atoms bear n oxo groups;
    • Ra (C1-C6)-alkyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and hydroxy;
    • Rb hydrogen or Ra;
    • Rc fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa or (C1-C6)-alkoxy, (C3-C6)-alkenyloxy or (C3-C6)-alkynyloxy, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Rd hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, phenyl-(C1-C3)-alkyl or (C2-C4)-alkynyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • Re Rd.
    • Rf (C1-C3)-alkyl or (C1-C3)-alkoxy;
    • Rh hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;
    • r 1, 2, 3, 4, 5 or 6;
    • m 0, 1, 2, 3, 4 or 5;
    • n 0, 1 or 2.


In particular, preferred compounds of the present invention are compounds of formula (I), wherein the substituents have the following meanings:

    • W1 —CH2—;
    • W2 —C(O)—;
    • R1 hydrogen;
    • R2 hydrogen;
    • R3 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R4 hydrogen or fluorine, preferably hydrogen;
    • R5 halogen, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy, preferably fluorine or chlorine;
    • R6 hydrogen;
    • R7 (C1-C6)-alkyl, (C2-C6)-alkenyl, (C1-C6)-haloalkyl, preferably methyl, ethenyl or trifluoromethyl;
    • R8 hydrogen;
    • X a bond;
    • Y Z;
    • Z a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals from the group consisting of CO2Re, and where the sulfur atoms and carbon atoms bear n oxo groups;
    • Re hydrogen or (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C4)-alkenyl, phenyl-(C1-C3)-alkyl (C3-C4)-alkynyl or (C3-C6)-cycloalkyl-(C1-C3)-alkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, phenylthio, phenylsulfinyl, and phenylsulfonyl;
    • r 1, 2, 3, 4, 5 or 6;
    • n 0, 1 or 2;
    • m 0, 1, 2, 3, 4 or 5.


Further preferred embodiments of compounds of formula (I) are compounds I.I to I.IV, wherein

    • (I.I): R1 is hydrogen, W1 is —O— and W2 is —CR9R10—:




embedded image




    • (I.II): R1 is hydrogen, W1 is —C(O)— and W2 is —CR9R10—:







embedded image




    • (I.III): R1 is hydrogen, W1 is —CR9R10— and W2 is —C(O)—:







embedded image




    • (I.IV): R1 is hydrogen, W1 is —CR9R10— and W2 is —CR9R10—:







embedded image


Compounds of formula (I.I.b.) wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R4, R6, R8, R9 and R10 are hydrogen are also particularly preferred:




embedded image


Compounds of formula (I.I.b.) wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R4, R6, R8, R9 and R10 are hydrogen are also particularly preferred:




embedded image


Compounds of formula (I.I.c.) wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, X is a bond (X0), and Y is Z are particularly preferred:




embedded image


Compounds of formula (I.I.d.) wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R4, R6, R8, R9 and R10 are hydrogen, X is a bond (X0), and Y is Z are also particularly preferred:




embedded image


Compounds of formula (I.II.a.) wherein W1 is —C(O)—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen are particularly preferred:




embedded image


Compounds of formula (I.II.b.) wherein W1 is —C(O)—, W is —CR9R10—, R1, R2, R4, R6, R8, R9 and R10 are hydrogen are particularly preferred:




embedded image


Compounds of formula (I.II.c.) wherein W1 is —C(O)—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, X is a bond (X0), and Y is Z are particularly preferred:




embedded image


Compounds of formula (I.II.d.) wherein W1 is —C(O)—, W2 is —CR9R10—, R1, R2, R4, R6, R8, R9 and R10 are hydrogen, X is a bond (X0), and Y is Z are also particularly preferred:




embedded image


Compounds of formula (I.III.a.) wherein W1 is —CR9R10—, W2 is —C(O)—, R1, R2, R6, R8, R9 and R10 are hydrogen are particularly preferred:




embedded image


Compounds of formula (I.III.b.) wherein W1 is —CR9R10—, W2 is —C(O)—, R1, R2, R4, R6, R8, R9 and R10 are hydrogen are also particularly preferred:




embedded image


Compounds of formula (I.III.c.) wherein W1 is —CR9R10—, W2 is —C(O)—, R1, R2, R6, R8, R9 and R10 are hydrogen, X is a bond (X0), and Y is Z are particularly preferred:




embedded image


Compounds of formula (I.III.d.) wherein W1 is —CR9R10—, W2 is —C(O)—, R1, R2, R4, R6, R8, R9 and R10 are hydrogen, X is a bond (X0), and Y is Z are also particularly preferred:




embedded image


Compounds of formula (I.IV.a.) wherein W1 and W2 are —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen are particularly preferred:




embedded image


Compounds of formula (I.IV.b.) wherein W1 and W2 are —CR9R10—, R1, R2, R4, R6, R8, R9 and R10 are hydrogen are also particularly preferred:




embedded image


Compounds of formula (I.IV.c.) wherein W1 and W2 are —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, X is a bond (X0), and Y is Z are particularly preferred:




embedded image


Compounds of formula (I.IV.d.) wherein W1 and W2 are —CR9R10—, R1, R2, R4, R6, R8, R9 and R10 are hydrogen, X is a bond (X0), and Y is Z are also particularly preferred:




embedded image


In the context of the present invention, compounds wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen (compounds I.I.a) and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 below, are particularly preferred.









TABLE 1







In Table 1,







embedded image







means cyclopropyl











Cpd.
R3
R4
R5
R7














1.
H
H
H
CH3


2.
F
H
H
CH3


3.
Cl
H
H
CH3


4.
Br
H
H
CH3


5.
I
H
H
CH3


6.
CN
H
H
CH3


7.
CH3
H
H
CH3


8.
CF3
H
H
CH3


9.
OCH3
H
H
CH3


10.
OCF3
H
H
CH3


11.
CH2CH3
H
H
CH3


12.
H
F
H
CH3


13.
F
F
H
CH3


14.
Cl
F
H
CH3


15.
Br
F
H
CH3


16.
I
F
H
CH3


17.
CN
F
H
CH3


18.
CH3
F
H
CH3


19.
CF3
F
H
CH3


20.
OCH3
F
H
CH3


21.
OCF3
F
H
CH3


22.
CH2CH3
F
H
CH3


23.
H
Cl
H
CH3


24.
F
Cl
H
CH3


25.
Cl
Cl
H
CH3


26.
Br
Cl
H
CH3


27.
I
Cl
H
CH3


28.
CN
Cl
H
CH3


29.
CH3
Cl
H
CH3


30.
CF3
Cl
H
CH3


31.
OCH3
Cl
H
CH3


32.
OCF3
Cl
H
CH3


33.
CH2CH3
Cl
H
CH3


34.
H
H
F
CH3


35.
F
H
F
CH3


36.
Cl
H
F
CH3


37.
Br
H
F
CH3


38.
I
H
F
CH3


39.
CN
H
F
CH3


40.
CH3
H
F
CH3


41.
CF3
H
F
CH3


42.
OCH3
H
F
CH3


43.
OCF3
H
F
CH3


44.
CH2CH3
H
F
CH3


45.
H
F
F
CH3


46.
F
F
F
CH3


47.
Cl
F
F
CH3


48.
Br
F
F
CH3


49.
I
F
F
CH3


50.
CN
F
F
CH3


51.
CH3
F
F
CH3


52.
CF3
F
F
CH3


53.
OCH3
F
F
CH3


54.
OCF3
F
F
CH3


55.
CH2CH3
F
F
CH3


56.
H
Cl
F
CH3


57.
F
Cl
F
CH3


58.
Cl
Cl
F
CH3


59.
Br
Cl
F
CH3


60.
Cl
Cl
F
CH3


61.
CN
Cl
F
CH3


62.
CH3
Cl
F
CH3


63.
CF3
Cl
F
CH3


64.
OCH3
Cl
F
CH3


65.
OCF3
Cl
F
CH3


66.
CH2CH3
Cl
F
CH3


67.
H
H
Cl
CH3


68.
F
H
Cl
CH3


69.
Cl
H
Cl
CH3


70.
Br
H
Cl
CH3


71.
I
H
Cl
CH3


72.
CN
H
Cl
CH3


73.
CH3
H
Cl
CH3


74.
CF3
H
Cl
CH3


75.
OCH3
H
Cl
CH3


76.
OCF3
H
Cl
CH3


77.
CH2CH3
H
Cl
CH3


78.
H
F
Cl
CH3


79.
F
F
Cl
CH3


80.
Cl
F
Cl
CH3


81.
Br
F
Cl
CH3


82.
I
F
Cl
CH3


83.
CN
F
Cl
CH3


84.
CH3
F
Cl
CH3


85.
CF3
F
Cl
CH3


86.
OCH3
F
Cl
CH3


87.
OCF3
F
Cl
CH3


88.
CH2CH3
F
Cl
CH3


89.
H
Cl
Cl
CH3


90.
F
Cl
Cl
CH3


91.
Cl
Cl
Cl
CH3


92.
Br
Cl
Cl
CH3


93.
I
Cl
Cl
CH3


94.
CN
Cl
Cl
CH3


95.
CH3
Cl
Cl
CH3


96.
CF3
Cl
Cl
CH3


97.
OCH3
Cl
Cl
CH3


98.
OCF3
Cl
Cl
CH3


99.
CH2CH3
Cl
Cl
CH3


100.
H
H
Br
CH3


101.
F
H
Br
CH3


102.
Cl
H
Br
CH3


103.
Br
H
Br
CH3


104.
I
H
Br
CH3


105.
CN
H
Br
CH3


106.
CH3
H
Br
CH3


107.
CF3
H
Br
CH3


108.
OCH3
H
Br
CH3


109.
OCF3
H
Br
CH3


110.
CH2CH3
H
Br
CH3


111.
H
F
Br
CH3


112.
F
F
Br
CH3


113.
Cl
F
Br
CH3


114.
Br
F
Br
CH3


115.
I
F
Br
CH3


116.
CN
F
Br
CH3


117.
CH3
F
Br
CH3


118.
CF3
F
Br
CH3


119.
OCH3
F
Br
CH3


120.
OCF3
F
Br
CH3


121.
CH2CH3
F
Br
CH3


122.
H
Cl
Br
CH3


123.
F
Cl
Br
CH3


124.
Cl
Cl
Br
CH3


125.
Br
Cl
Br
CH3


126.
I
Cl
Br
CH3


127.
CN
Cl
Br
CH3


128.
CH3
Cl
Br
CH3


129.
CF3
Cl
Br
CH3


130.
OCH3
Cl
Br
CH3


131.
OCF3
Cl
Br
CH3


132.
CH2CH3
Cl
Br
CH3


133.
H
H
I
CH3


134.
F
H
I
CH3


135.
Cl
H
I
CH3


136.
Br
H
I
CH3


137.
I
H
I
CH3


138.
CN
H
I
CH3


139.
CH3
H
I
CH3


140.
CF3
H
I
CH3


141.
OCH3
H
I
CH3


142.
OCF3
H
I
CH3


143.
CH2CH3
H
I
CH3


144.
H
F
I
CH3


145.
F
F
I
CH3


146.
Cl
F
I
CH3


147.
Br
F
I
CH3


148.
I
F
I
CH3


149.
CN
F
I
CH3


150.
CH3
F
I
CH3


151.
CF3
F
I
CH3


152.
OCH3
F
I
CH3


153.
OCF3
F
I
CH3


154.
CH2CH3
F
I
CH3


155.
H
Cl
I
CH3


156.
F
Cl
I
CH3


157.
Cl
Cl
I
CH3


158.
Br
Cl
I
CH3


159.
I
Cl
I
CH3


160.
CN
Cl
I
CH3


161.
CH3
Cl
I
CH3


162.
CF3
Cl
I
CH3


163.
OCH3
Cl
I
CH3


164.
OCF3
Cl
I
CH3


165.
CH2CH3
Cl
I
CH3


166.
H
H
CN
CH3


167.
F
H
CN
CH3


168.
Cl
H
CN
CH3


169.
Br
H
CN
CH3


170.
I
H
CN
CH3


171.
CN
H
CN
CH3


172.
CH3
H
CN
CH3


173.
CF3
H
CN
CH3


174.
OCH3
H
CN
CH3


175.
OCF3
H
CN
CH3


176.
CH2CH3
H
CN
CH3


177.
H
F
CN
CH3


178.
F
F
CN
CH3


179.
Cl
F
CN
CH3


180.
Br
F
CN
CH3


181.
I
F
CN
CH3


182.
CN
F
CN
CH3


183.
CH3
F
CN
CH3


184.
CF3
F
CN
CH3


185.
OCH3
F
CN
CH3


186.
OCF3
F
CN
CH3


187.
CH2CH3
F
CN
CH3


188.
H
Cl
CN
CH3


189.
F
Cl
CN
CH3


190.
Cl
Cl
CN
CH3


191.
Br
Cl
CN
CH3


192.
I
Cl
CN
CH3


193.
CN
Cl
CN
CH3


194.
CH3
Cl
CN
CH3


195.
CF3
Cl
CN
CH3


196.
OCH3
Cl
CN
CH3


197.
OCF3
Cl
CN
CH3


198.
CH2CH3
Cl
CN
CH3


199.
H
H
CH3
CH3


200.
F
H
CH3
CH3


201.
Cl
H
CH3
CH3


202.
Br
H
CH3
CH3


203.
I
H
CH3
CH3


204.
CN
H
CH3
CH3


205.
CH3
H
CH3
CH3


206.
CF3
H
CH3
CH3


207.
OCH3
H
CH3
CH3


208.
OCF3
H
CH3
CH3


209.
CH2CH3
H
CH3
CH3


210.
H
F
CH3
CH3


211.
F
F
CH3
CH3


212.
Cl
F
CH3
CH3


213.
Br
F
CH3
CH3


214.
I
F
CH3
CH3


215.
CN
F
CH3
CH3


216.
CH3
F
CH3
CH3


217.
CF3
F
CH3
CH3


218.
OCH3
F
CH3
CH3


219.
OCF3
F
CH3
CH3


220.
CH2CH3
F
CH3
CH3


221.
H
Cl
CH3
CH3


222.
F
Cl
CH3
CH3


223.
Cl
Cl
CH3
CH3


224.
Br
Cl
CH3
CH3


225.
I
Cl
CH3
CH3


226.
CN
Cl
CH3
CH3


227.
CH3
Cl
CH3
CH3


228.
CF3
Cl
CH3
CH3


229.
OCH3
Cl
CH3
CH3


230.
OCF3
Cl
CH3
CH3


231.
CH2CH3
Cl
CH3
CH3


232.
H
H
H
CHCH2


233.
F
H
H
CHCH2


234.
Cl
H
H
CHCH2


235.
Br
H
H
CHCH2


236.
I
H
H
CHCH2


237.
CN
H
H
CHCH2


238.
CH3
H
H
CHCH2


239.
CF3
H
H
CHCH2


240.
OCH3
H
H
CHCH2


241.
OCF3
H
H
CHCH2


242.
CH2CH3
H
H
CHCH2


243.
H
F
H
CHCH2


244.
F
F
H
CHCH2


245.
Cl
F
H
CHCH2


246.
Br
F
H
CHCH2


247.
I
F
H
CHCH2


248.
CN
F
H
CHCH2


249.
CH3
F
H
CHCH2


250.
CF3
F
H
CHCH2


251.
OCH3
F
H
CHCH2


252.
OCF3
F
H
CHCH2


253.
CH2CH3
F
H
CHCH2


254.
H
Cl
H
CHCH2


255.
F
Cl
H
CHCH2


256.
Cl
Cl
H
CHCH2


257.
Br
Cl
H
CHCH2


258.
I
Cl
H
CHCH2


259.
CN
Cl
H
CHCH2


260.
CH3
Cl
H
CHCH2


261.
CF3
Cl
H
CHCH2


262.
OCH3
Cl
H
CHCH2


263.
OCF3
Cl
H
CHCH2


264.
CH2CH3
Cl
H
CHCH2


265.
H
H
F
CHCH2


266.
F
H
F
CHCH2


267.
Cl
H
F
CHCH2


268.
Br
H
F
CHCH2


269.
I
H
F
CHCH2


270.
CN
H
F
CHCH2


271.
CH3
H
F
CHCH2


272.
CF3
H
F
CHCH2


273.
OCH3
H
F
CHCH2


274.
OCF3
H
F
CHCH2


275.
CH2CH3
H
F
CHCH2


276.
H
F
F
CHCH2


277.
F
F
F
CHCH2


278.
Cl
F
F
CHCH2


279.
Br
F
F
CHCH2


280.
I
F
F
CHCH2


281.
CN
F
F
CHCH2


282.
CH3
F
F
CHCH2


283.
CF3
F
F
CHCH2


284.
OCH3
F
F
CHCH2


285.
OCF3
F
F
CHCH2


286.
CH2CH3
F
F
CHCH2


287.
H
Cl
F
CHCH2


288.
F
Cl
F
CHCH2


289.
Cl
Cl
F
CHCH2


290.
Br
Cl
F
CHCH2


291.
I
Cl
F
CHCH2


292.
CN
Cl
F
CHCH2


293.
CH3
Cl
F
CHCH2


294.
CF3
Cl
F
CHCH2


295.
OCH3
Cl
F
CHCH2


296.
OCF3
Cl
F
CHCH2


297.
CH2CH3
Cl
F
CHCH2


298.
H
H
Cl
CHCH2


299.
F
H
Cl
CHCH2


300.
Cl
H
Cl
CHCH2


301.
Br
H
Cl
CHCH2


302.
I
H
Cl
CHCH2


303.
CN
H
Cl
CHCH2


304.
CH3
H
Cl
CHCH2


305.
CF3
H
Cl
CHCH2


306.
OCH3
H
Cl
CHCH2


307.
OCF3
H
Cl
CHCH2


308.
CH2CH3
H
Cl
CHCH2


309.
H
F
Cl
CHCH2


310.
F
F
Cl
CHCH2


311.
Cl
F
Cl
CHCH2


312.
Br
F
Cl
CHCH2


313.
I
F
Cl
CHCH2


314.
CN
F
Cl
CHCH2


315.
CH3
F
Cl
CHCH2


316.
CF3
F
Cl
CHCH2


317.
OCH3
F
Cl
CHCH2


318.
OCF3
F
Cl
CHCH2


319.
CH2CH3
F
Cl
CHCH2


320.
H
Cl
Cl
CHCH2


321.
F
Cl
Cl
CHCH2


322.
Cl
Cl
Cl
CHCH2


323.
Br
Cl
Cl
CHCH2


324.
I
Cl
Cl
CHCH2


325.
CN
Cl
Cl
CHCH2


326.
CH3
Cl
Cl
CHCH2


327.
CF3
Cl
Cl
CHCH2


328.
OCH3
Cl
Cl
CHCH2


329.
OCF3
Cl
Cl
CHCH2


330.
CH2CH3
Cl
Cl
CHCH2


331.
H
H
Br
CHCH2


332.
F
H
Br
CHCH2


333.
Cl
H
Br
CHCH2


334.
Br
H
Br
CHCH2


335.
I
H
Br
CHCH2


336.
CN
H
Br
CHCH2


337.
CH3
H
Br
CHCH2


338.
CF3
H
Br
CHCH2


339.
OCH3
H
Br
CHCH2


340.
OCF3
H
Br
CHCH2


341.
CH2CH3
H
Br
CHCH2


342.
H
F
Br
CHCH2


343.
F
F
Br
CHCH2


344.
Cl
F
Br
CHCH2


345.
Br
F
Br
CHCH2


346.
I
F
Br
CHCH2


347.
CN
F
Br
CHCH2


348.
CH3
F
Br
CHCH2


349.
CF3
F
Br
CHCH2


350.
OCH3
F
Br
CHCH2


351.
OCF3
F
Br
CHCH2


352.
CH2CH3
F
Br
CHCH2


353.
H
Cl
Br
CHCH2


354.
F
Cl
Br
CHCH2


355.
Cl
Cl
Br
CHCH2


356.
Br
Cl
Br
CHCH2


357.
I
Cl
Br
CHCH2


358.
CN
Cl
Br
CHCH2


359.
CH3
Cl
Br
CHCH2


360.
CF3
Cl
Br
CHCH2


361.
OCH3
Cl
Br
CHCH2


362.
OCF3
Cl
Br
CHCH2


363.
CH2CH3
Cl
Br
CHCH2


364.
H
H
I
CHCH2


365.
F
H
I
CHCH2


366.
Cl
H
I
CHCH2


367.
Br
H
I
CHCH2


368.
I
H
I
CHCH2


369.
CN
H
I
CHCH2


370.
CH3
H
I
CHCH2


371.
CF3
H
I
CHCH2


372.
OCH3
H
I
CHCH2


373.
OCF3
H
I
CHCH2


374.
CH2CH3
H
I
CHCH2


375.
H
F
I
CHCH2


376.
F
F
I
CHCH2


377.
Cl
F
I
CHCH2


378.
Br
F
I
CHCH2


379.
I
F
I
CHCH2


380.
CN
F
I
CHCH2


381.
CH3
F
I
CHCH2


382.
CF3
F
I
CHCH2


383.
OCH3
F
I
CHCH2


384.
OCF3
F
I
CHCH2


385.
CH2CH3
F
I
CHCH2


386.
H
Cl
I
CHCH2


387.
F
Cl
I
CHCH2


388.
Cl
Cl
I
CHCH2


389.
Br
Cl
I
CHCH2


390.
I
Cl
I
CHCH2


391.
CN
Cl
I
CHCH2


392.
CH3
Cl
I
CHCH2


393.
CF3
Cl
I
CHCH2


394.
OCH3
Cl
I
CHCH2


395.
OCF3
Cl
I
CHCH2


396.
CH2CH3
Cl
I
CHCH2


397.
H
H
CN
CHCH2


398.
F
H
CN
CHCH2


399.
Cl
H
CN
CHCH2


400.
Br
H
CN
CHCH2


401.
I
H
CN
CHCH2


402.
CN
H
CN
CHCH2


403.
CH3
H
CN
CHCH2


404.
CF3
H
CN
CHCH2


405.
OCH3
H
CN
CHCH2


406.
OCF3
H
CN
CHCH2


407.
CH2CH3
H
CN
CHCH2


408.
H
F
CN
CHCH2


409.
F
F
CN
CHCH2


410.
Cl
F
CN
CHCH2


411.
Br
F
CN
CHCH2


412.
I
F
CN
CHCH2


413.
CN
F
CN
CHCH2


414.
CH3
F
CN
CHCH2


415.
CF3
F
CN
CHCH2


416.
OCH3
F
CN
CHCH2


417.
OCF3
F
CN
CHCH2


418.
CH2CH3
F
CN
CHCH2


419.
H
Cl
CN
CHCH2


420.
F
Cl
CN
CHCH2


421.
Cl
Cl
CN
CHCH2


422.
Br
Cl
CN
CHCH2


423.
I
Cl
CN
CHCH2


424.
CN
Cl
CN
CHCH2


425.
CH3
Cl
CN
CHCH2


426.
CF3
Cl
CN
CHCH2


427.
OCH3
Cl
CN
CHCH2


428.
OCF3
Cl
CN
CHCH2


429.
CH2CH3
Cl
CN
CHCH2


430.
H
H
CH3
CHCH2


431.
F
H
CH3
CHCH2


432.
Cl
H
CH3
CHCH2


433.
Br
H
CH3
CHCH2


434.
I
H
CH3
CHCH2


435.
CN
H
CH3
CHCH2


436.
CH3
H
CH3
CHCH2


437.
CF
H
CH3
CHCH2


438.
OCH3
H
CH3
CHCH2


439.
OCF3
H
CH3
CHCH2


440.
CH2CH3
H
CH3
CHCH2


441.
H
F
CH3
CHCH2


442.
F
F
CH3
CHCH2


443.
Cl
F
CH3
CHCH2


444.
Br
F
CH3
CHCH2


445.
I
F
CH3
CHCH2


446.
CN
F
CH3
CHCH2


447.
CH3
F
CH3
CHCH2


448.
CF3
F
CH3
CHCH2


449.
OCH3
F
CH3
CHCH2


450.
OCF3
F
CH3
CHCH2


451.
CH2CH3
F
CH3
CHCH2


452.
H
Cl
CH3
CHCH2


453.
F
Cl
CH3
CHCH2


454.
Cl
Cl
CH3
CHCH2


455.
Br
Cl
CH3
CHCH2


456.
I
Cl
CH3
CHCH2


457.
CN
Cl
CH3
CHCH2


458.
CH3
Cl
CH3
CHCH2


459.
CF3
Cl
CH3
CHCH2


460.
OCH3
Cl
CH3
CHCH2


461.
OCF3
Cl
CH3
CHCH2


462.
CH2CH3
Cl
CH3
CHCH2


463.
H
H
H
CF3


464.
F
H
H
CF3


465.
Cl
H
H
CF3


466.
Br
H
H
CF


467.
I
H
H
CF3


468.
CN
H
H
CF3


469.
CH3
H
H
CF3


470.
CF3
H
H
CF3


471.
OCH3
H
H
CF3


472.
OCF3
H
H
CF3


473.
CH2CH3
H
H
CF3


474.
H
F
H
CF3


475.
F
F
H
CF3


476.
Cl
F
H
CF


477.
Br
F
H
CF3


478.
I
F
H
CF3


479.
CN
F
H
CF3


480.
CH3
F
H
CF3


481.
CF3
F
H
CF3


482.
OCH3
F
H
CF3


483.
OCF3
F
H
CF3


484.
CH2CH3
F
H
CF3


485.
H
Cl
H
CF3


486.
F
Cl
H
CF3


487.
Cl
Cl
H
CF3


488.
Br
Cl
H
CF3


489.
I
Cl
H
CF3


490.
CN
Cl
H
CF3


491.
CH3
Cl
H
CF3


492.
CF3
Cl
H
CF3


493.
OCH3
Cl
H
CF3


494.
OCF3
Cl
H
CF3


495.
CH2CH3
Cl
H
CF3


496.
H
H
F
CF3


497.
F
H
F
CF3


498.
Cl
H
F
CF3


499.
Br
H
F
CF3


500.
I
H
F
CF3


501.
CN
H
F
CF3


502.
CH3
H
F
CF3


503.
CF3
H
F
CF3


504.
OCH3
H
F
CF3


505.
OCF3
H
F
CF3


506.
CH2CH3
H
F
CF3


507.
H
F
F
CF3


508.
F
F
F
CF3


509.
Cl
F
F
CF3


510.
Br
F
F
CF3


511.
I
F
F
CF3


512.
CN
F
F
CF3


513.
CH3
F
F
CF3


514.
CF3
F
F
CF3


515.
OCH3
F
F
CF3


516.
OCF3
F
F
CF3


517.
CH2CH3
F
F
CF3


518.
H
Cl
F
CF3


519.
F
Cl
F
CF3


520.
Cl
Cl
F
CF3


521.
Br
Cl
F
CF3


522.
I
Cl
F
CF3


523.
CN
Cl
F
CF3


524.
CH3
Cl
F
CF3


525.
CF3
Cl
F
CF3


526.
OCH3
Cl
F
CF3


527.
OCF3
Cl
F
CF3


528.
CH2CH3
Cl
F
CF3


529.
H
H
Cl
CF3


530.
F
H
Cl
CF3


531.
Cl
H
Cl
CF3


532.
Br
H
Cl
CF3


533.
I
H
Cl
CF3


534.
CN
H
Cl
CF3


535.
CH3
H
Cl
CF3


536.
CF3
H
Cl
CF3


537.
OCH3
H
Cl
CF3


538.
OCF3
H
Cl
CF3


539.
CH2CH3
H
Cl
CF3


540.
H
F
Cl
CF3


541.
F
F
Cl
CF3


542.
Cl
F
Cl
CF3


543.
Br
F
Cl
CF3


544.
I
F
Cl
CF3


545.
CN
F
Cl
CF3


546.
CH3
F
Cl
CF3


547.
CF3
F
Cl
CF3


548.
OCH3
F
Cl
CF3


549.
OCF3
F
Cl
CF3


550.
CH2CH3
F
Cl
CF3


551.
H
Cl
Cl
CF3


552.
F
Cl
Cl
CF3


553.
Cl
Cl
Cl
CF3


554.
Br
Cl
Cl
CF3


555.
I
Cl
Cl
CF3


556.
CN
Cl
Cl
CF3


557.
CH3
Cl
Cl
CF3


558.
CF3
Cl
Cl
CF3


559.
OCH3
Cl
Cl
CF3


560.
OCF3
Cl
Cl
CF3


561.
CH2CH3
Cl
Cl
CF3


562.
H
H
Br
CF3


563.
F
H
Br
CF3


564.
Cl
H
Br
CF3


565.
Br
H
Br
CF3


566.
I
H
Br
CF3


567.
CN
H
Br
CF3


568.
CH3
H
Br
CF3


569.
CF3
H
Br
CF3


570.
OCH3
H
Br
CF3


571.
OCF3
H
Br
CF3


572.
CH2CH3
H
Br
CF3


573.
H
F
Br
CF3


574.
F
F
Br
CF3


575.
Cl
F
Br
CF3


576.
Br
F
Br
CF3


577.
I
F
Br
CF3


578.
CN
F
Br
CF3


579.
CH3
F
Br
CF3


580.
CF3
F
Br
CF3


581.
OCH3
F
Br
CF3


582.
OCF3
F
Br
CF3


583.
CH2CH3
F
Br
CF3


584.
H
Cl
Br
CF3


585.
F
Cl
Br
CF3


586.
Cl
Cl
Br
CF3


587.
Br
Cl
Br
CF3


588.
I
Cl
Br
CF3


589.
CN
Cl
Br
CF3


590.
CH3
Cl
Br
CF3


591.
CF3
Cl
Br
CF3


592.
OCH3
Cl
Br
CF3


593.
OCF3
Cl
Br
CF3


594.
CH2CH3
Cl
Br
CF3


595.
H
H
I
CF3


596.
F
H
I
CF3


597.
Cl
H
I
CF3


598.
Br
H
I
CF3


599.
I
H
I
CF3


600.
CN
H
I
CF3


601.
CH3
H
I
CF3


602.
CF3
H
I
CF3


603.
OCH3
H
I
CF3


604.
OCF3
H
I
CF3


605.
CH2CH3
H
I
CF3


606.
H
F
I
CF3


607.
F
F
I
CF3


608.
Cl
F
I
CF3


609.
Br
F
I
CF3


610.
I
F
I
CF3


611.
CN
F
I
CF3


612.
CH3
F
I
CF3


613.
CF3
F
I
CF3


614.
OCH3
F
I
CF3


615.
OCF3
F
I
CF3


616.
CH2CH3
F
I
CF3


617.
H
Cl
I
CF3


618.
F
Cl
I
CF3


619.
Cl
Cl
I
CF3


620.
Br
Cl
I
CF3


621.
I
Cl
I
CF3


622.
CN
Cl
I
CF3


623.
CH3
Cl
I
CF3


624.
CF3
Cl
I
CF3


625.
OCH3
Cl
I
CF3


626.
OCF3
Cl
I
CF3


627.
CH2CH3
Cl
I
CF3


628.
H
H
CN
CF3


629.
F
H
CN
CF3


630.
Cl
H
CN
CF3


631.
Br
H
CN
CF3


632.
I
H
CN
CF3


633.
CN
H
CN
CF3


634.
CH3
H
CN
CF3


635.
CF3
H
CN
CF3


636.
OCH3
H
CN
CF3


637.
OCF3
H
CN
CF3


638.
CH2CH3
H
CN
CF3


639.
H
F
CN
CF3


640.
F
F
CN
CF3


641.
Cl
F
CN
CF3


642.
Br
F
CN
CF3


643.
I
F
CN
CF3


644.
CN
F
CN
CF3


645.
CH3
F
CN
CF3


646.
CF3
F
CN
CF3


647.
OCH3
F
CN
CF3


648.
OCF3
F
CN
CF3


649.
CH2CH3
F
CN
CF3


650.
H
Cl
CN
CF3


651.
F
Cl
CN
CF3


652.
Cl
Cl
CN
CF3


653.
Br
Cl
CN
CF3


654.
I
Cl
CN
CF3


655.
CN
Cl
CN
CF3


656.
CH3
Cl
CN
CF3


657.
CF3
Cl
CN
CF3


658.
OCH3
Cl
CN
CF3


659.
OCF3
Cl
CN
CF3


660.
CH2CH3
Cl
CN
CF3


661.
H
H
CH3
CF3


662.
F
H
CH3
CF3


663.
Cl
H
CH3
CF3


664.
Br
H
CH3
CF3


665.
I
H
CH3
CF3


666.
CN
H
CH3
CF3


667.
CH3
H
CH3
CF3


668.
CF3
H
CH3
CF3


669.
OCH3
H
CH3
CF3


670.
OCF3
H
CH3
CF3


671.
CH2CH3
H
CH3
CF


672.
H
F
CH3
CF3


673.
F
F
CH3
CF3


674.
Cl
F
CH3
CF3


675.
Br
F
CH3
CF3


676.
I
F
CH3
CF3


677.
CN
F
CH3
CF3


678.
CH3
F
CH3
CF3


679.
CF3
F
CH3
CF3


680.
OCH3
F
CH3
CF3


681.
OCF3
F
CH3
CF3


682.
CH2CH3
F
CH3
CF3


683.
H
Cl
CH3
CF3


684.
F
Cl
CH3
CF3


685.
Cl
Cl
CH3
CF3


686.
Br
Cl
CH3
CF3


687.
I
Cl
CH3
CF3


688.
CN
Cl
CH3
CF3


689.
CH3
Cl
CH3
CF3


690.
CF3
Cl
CH3
CF3


691.
OCH3
Cl
CH3
CF3


692.
OCF3
Cl
CH3
CF3


693.
CH2CH3
Cl
CH3
CF3





694.
H
H
H


embedded image







695.
F
H
H


embedded image







696.
Cl
H
H


embedded image







697.
Br
H
H


embedded image







698.
I
H
H


embedded image







699.
CN
H
H


embedded image







700.
CH3
H
H


embedded image







701.
CF3
H
H


embedded image







702.
OCH3
H
H


embedded image







703.
OCF3
H
H


embedded image







704.
CH2CH3
H
H


embedded image







705.
H
F
H


embedded image







706.
F
F
H


embedded image







707.
Cl
F
H


embedded image







708.
Br
F
H


embedded image







709.
I
F
H


embedded image







710.
CN
F
H


embedded image







711.
CH3
F
H


embedded image







712.
CF3
F
H


embedded image







713.
OCH3
F
H


embedded image







714.
OCF3
F
H


embedded image







715.
CH2CH3
F
H


embedded image







716.
H
Cl
H


embedded image







717.
F
Cl
H


embedded image







718.
Cl
Cl
H


embedded image







719.
Br
Cl
H


embedded image







720.
I
Cl
H


embedded image







721.
CN
Cl
H


embedded image







722.
CH3
Cl
H


embedded image







723.
CF3
Cl
H


embedded image







724.
OCH3
Cl
H


embedded image







725.
OCF3
Cl
H


embedded image







726.
CH2CH3
Cl
H


embedded image







727.
H
H
F


embedded image







728.
F
H
F


embedded image







729.
Cl
H
F


embedded image







730.
Br
H
F


embedded image







731.
I
H
F


embedded image







732.
CN
H
F


embedded image







733.
CH3
H
F


embedded image







734.
CF3
H
F


embedded image







735.
OCH3
H
F


embedded image







736.
OCF3
H
F


embedded image







737.
CH2CH3
H
F


embedded image







738.
H
F
F


embedded image







739.
F
F
F


embedded image







740.
Cl
F
F


embedded image







741.
Br
F
F


embedded image







742.
I
F
F


embedded image







743.
CN
F
F


embedded image







744.
CH3
F
F


embedded image







745.
CF3
F
F


embedded image







746.
OCH3
F
F


embedded image







747.
OCF3
F
F


embedded image







748.
CH2CH3
F
F


embedded image







749.
H
Cl
F


embedded image







750.
F
Cl
F


embedded image







751.
Cl
Cl
F


embedded image







752.
Br
Cl
F


embedded image







753.
I
Cl
F


embedded image







754.
CN
Cl
F


embedded image







755.
CH3
Cl
F


embedded image







756.
CF3
Cl
F


embedded image







757.
OCH3
Cl
F


embedded image







758.
OCF3
Cl
F


embedded image







759.
CH2CH3
Cl
F


embedded image







760.
H
H
Cl


embedded image







761.
F
H
Cl


embedded image







762.
Cl
H
Cl


embedded image







763.
Br
H
Cl


embedded image







764.
I
H
Cl


embedded image







765.
CN
H
Cl


embedded image







766.
CH3
H
Cl


embedded image







767.
CF3
H
Cl


embedded image







768.
OCH3
H
Cl


embedded image







769.
OCF3
H
Cl


embedded image







770.
CH2CH3
H
Cl


embedded image







771.
H
F
Cl


embedded image







772.
F
F
Cl


embedded image







773.
Cl
F
Cl


embedded image







774.
Br
F
Cl


embedded image







775.
I
F
Cl


embedded image







776.
CN
F
Cl


embedded image







777.
CH3
F
Cl


embedded image







778.
CF3
F
Cl


embedded image







779.
OCH3
F
Cl


embedded image







780.
OCF3
F
Cl


embedded image







781.
CH2CH3
F
Cl


embedded image







782.
H
Cl
Cl


embedded image







783.
F
Cl
Cl


embedded image







784.
Cl
Cl
Cl


embedded image







785.
Br
Cl
Cl


embedded image







786.
I
Cl
Cl


embedded image







787.
CN
Cl
Cl


embedded image







788.
CH3
Cl
Cl


embedded image







789.
CF3
Cl
Cl


embedded image







790.
OCH3
Cl
Cl


embedded image







791.
OCF3
Cl
Cl


embedded image







792.
CH2CH3
Cl
Cl


embedded image







793.
H
H
Br


embedded image







794.
F
H
Br


embedded image







795.
Cl
H
Br


embedded image







796.
Br
H
Br


embedded image







797.
I
H
Br


embedded image







798.
CN
H
Br


embedded image







799.
CH3
H
Br


embedded image







800.
CF3
H
Br


embedded image







801.
OCH3
H
Br


embedded image







802.
OCF3
H
Br


embedded image







803.
CH2CH3
H
Br


embedded image







804.
H
F
Br


embedded image







805.
F
F
Br


embedded image







806.
Cl
F
Br


embedded image







807.
Br
F
Br


embedded image







808.
I
F
Br


embedded image







809.
CN
F
Br


embedded image







810.
CH3
F
Br


embedded image







811.
CF3
F
Br


embedded image







812.
OCH3
F
Br


embedded image







813.
OCF3
F
Br


embedded image







814.
CH2CH3
F
Br


embedded image







815.
H
Cl
Br


embedded image







816.
F
Cl
Br


embedded image







817.
Cl
Cl
Br


embedded image







818.
Br
Cl
Br


embedded image







819.
I
Cl
Br


embedded image







820.
CN
Cl
Br


embedded image







821.
CH3
Cl
Br


embedded image







822.
CF3
Cl
Br


embedded image







823.
OCH3
Cl
Br


embedded image







824.
OCF3
Cl
Br


embedded image







825.
CH2CH3
Cl
Br


embedded image







826.
H
H
I


embedded image







827.
F
H
I


embedded image







828.
Cl
H
I


embedded image







829.
Br
H
I


embedded image







830.
I
H
I


embedded image







831.
CN
H
I


embedded image







832.
CH3
H
I


embedded image







833.
CF3
H
I


embedded image







834.
OCH3
H
I


embedded image







835.
OCF3
H
I


embedded image







836.
CH2CH3
H
I


embedded image







837.
H
F
I


embedded image







838.
F
F
I


embedded image







839.
Cl
F
I


embedded image







840.
Br
F
I


embedded image







841.
I
F
I


embedded image







842.
CN
F
I


embedded image







843.
CH3
F
I


embedded image







844.
CF3
F
I


embedded image







845.
OCH3
F
I


embedded image







846.
OCF3
F
I


embedded image







847.
CH2CH3
F
I


embedded image







848.
H
Cl
I


embedded image







849.
F
Cl
I


embedded image







850.
Cl
Cl
I


embedded image







851.
Br
Cl
I


embedded image







852.
I
Cl
I


embedded image







853.
CN
Cl
I


embedded image







854.
CH3
Cl
I


embedded image







855.
CF3
Cl
I


embedded image







856.
OCH3
Cl
I


embedded image







857.
OCF3
Cl
I


embedded image







858.
CH2CH3
Cl
I


embedded image







859.
H
H
CN


embedded image







860.
F
H
CN


embedded image







861.
Cl
H
CN


embedded image







862.
Br
H
CN


embedded image







863.
I
H
CN


embedded image







864.
CN
H
CN


embedded image







865.
CH3
H
CN


embedded image







866.
CF3
H
CN


embedded image







867.
OCH3
H
CN


embedded image







868.
OCF3
H
CN


embedded image







869.
CH2CH3
H
CN


embedded image







870.
H
F
CN


embedded image







871.
F
F
CN


embedded image







872.
Cl
F
CN


embedded image







873.
Br
F
CN


embedded image







874.
I
F
CN


embedded image







875.
CN
F
CN


embedded image







876.
CH3
F
CN


embedded image







877.
CF3
F
CN


embedded image







878.
OCH3
F
CN


embedded image







879.
OCF3
F
CN


embedded image







880.
CH2CH3
F
CN


embedded image







881.
H
Cl
CN


embedded image







882.
F
Cl
CN


embedded image







883.
Cl
Cl
CN


embedded image







884.
Br
Cl
CN


embedded image







885.
I
Cl
CN


embedded image







886.
CN
Cl
CN


embedded image







887.
CH3
Cl
CN


embedded image







888.
CF3
Cl
CN


embedded image







889.
OCH3
Cl
CN


embedded image







890.
OCF3
Cl
CN


embedded image







891.
CH2CH3
Cl
CN


embedded image







892.
H
H
CH3


embedded image







893.
F
H
CH3


embedded image







894.
Cl
H
CH3


embedded image







895.
Br
H
CH3


embedded image







896.
I
H
CH3


embedded image







897.
CN
H
CH3


embedded image







898.
CH3
H
CH3


embedded image







899.
CF3
H
CH3


embedded image







900.
OCH3
H
CH3


embedded image







901.
OCF3
H
CH3


embedded image







902.
CH2CH3
H
CH3


embedded image







903.
H
F
CH3


embedded image







904.
F
F
CH3


embedded image







905.
Cl
F
CH3


embedded image







906.
Br
F
CH3


embedded image







907.
I
F
CH3


embedded image







908.
CN
F
CH3


embedded image







909.
CH3
F
CH3


embedded image







910.
CF3
F
CH3


embedded image







911.
OCH3
F
CH3


embedded image







912.
OCF3
F
CH3


embedded image







913.
CH2CH3
F
CH3


embedded image







914.
H
Cl
CH3


embedded image







915.
F
Cl
CH3


embedded image







916.
Cl
Cl
CH3


embedded image







917.
Br
Cl
CH3


embedded image







918.
I
Cl
CH3


embedded image







919.
CN
Cl
CH3


embedded image







920.
CH3
Cl
CH3


embedded image







921.
CF3
Cl
CH3


embedded image







922.
OCH3
Cl
CH3


embedded image







923.
OCF3
Cl
CH3


embedded image







924.
CH2CH3
Cl
CH3


embedded image







925.
H
H
H
CH2CH3


926.
F
H
H
CH2CH3


927.
Cl
H
H
CH2CH3


928.
Br
H
H
CH2CH3


929.
I
H
H
CH2CH3


930.
CN
H
H
CH2CH3


931.
CH3
H
H
CH2CH3


932.
CF3
H
H
CH2CH3


933.
OCH3
H
H
CH2CH3


934.
OCF3
H
H
CH2CH3


935.
CH2CH3
H
H
CH2CH3


936.
H
F
H
CH2CH3


937.
F
F
H
CH2CH3


938.
Cl
F
H
CH2CH3


939.
Br
F
H
CH2CH3


940.
I
F
H
CH2CH3


941.
CN
F
H
CH2CH3


942.
CH3
F
H
CH2CH3


943.
CF3
F
H
CH2CH3


944.
OCH3
F
H
CH2CH3


945.
OCF3
F
H
CH2CH3


946.
CH2CH3
F
H
CH2CH3


947.
H
Cl
H
CH2CH3


948.
F
Cl
H
CH2CH3


949.
Cl
Cl
H
CH2CH3


950.
Br
Cl
H
CH2CH3


951.
I
Cl
H
CH2CH3


952.
CN
Cl
H
CH2CH3


953.
CH3
Cl
H
CH2CH3


954.
CF3
Cl
H
CH2CH3


955.
OCH3
Cl
H
CH2CH3


956.
OCF3
Cl
H
CH2CH3


957.
CH2CH3
Cl
H
CH2CH3


958.
H
H
F
CH2CH3


971.
Cl
F
F
CH2CH3


972.
Br
F
F
CH2CH3


973.
I
F
F
CH2CH3


974.
CN
F
F
CH2CH3


975.
CH3
F
F
CH2CH3


976.
CF3
F
F
CH2CH3


977.
OCH3
F
F
CH2CH3


978.
OCF3
F
F
CH2CH3


979.
CH2CH3
F
F
CH2CH3


980.
H
Cl
F
CH2CH3


981.
F
Cl
F
CH2CH3


982.
Cl
Cl
F
CH2CH3


983.
Br
Cl
F
CH2CH3


984.
I
Cl
F
CH2CH3


985.
CN
Cl
F
CH2CH3


986.
CH3
Cl
F
CH2CH3


987.
CF3
Cl
F
CH2CH3


988.
OCH3
Cl
F
CH2CH3


989.
OCF3
Cl
F
CH2CH3


990.
CH2CH3
Cl
F
CH2CH3


991.
H
H
Cl
CH2CH3


992.
F
H
Cl
CH2CH3


993.
Cl
H
Cl
CH2CH3


994.
Br
H
Cl
CH2CH3


995.
I
H
Cl
CH2CH3


996.
CN
H
Cl
CH2CH3


997.
CH3
H
Cl
CH2CH3


998.
CF3
H
Cl
CH2CH3


999.
OCH3
H
Cl
CH2CH3


1000.
OCF3
H
Cl
CH2CH3


1001.
CH2CH3
H
Cl
CH2CH3


1002.
H
F
Cl
CH2CH3


1003.
F
F
Cl
CH2CH3


1004.
Cl
F
Cl
CH2CH3


1005.
Br
F
Cl
CH2CH3


1006.
I
F
Cl
CH2CH3


1007.
CN
F
Cl
CH2CH3


1008.
CH3
F
Cl
CH2CH3


1009.
CF3
F
Cl
CH2CH3


1010.
OCH3
F
Cl
CH2CH3


1011.
OCF3
F
Cl
CH2CH3


1012.
CH2CH3
F
Cl
CH2CH3


1013.
H
Cl
Cl
CH2CH3


1014.
F
Cl
Cl
CH2CH3


1015.
Cl
Cl
Cl
CH2CH3


1016.
Br
Cl
Cl
CH2CH3


1017.
I
Cl
Cl
CH2CH3


1018.
CN
Cl
Cl
CH2CH3


1019.
CH3
Cl
Cl
CH2CH3


1020.
CF3
Cl
Cl
CH2CH3


1021.
OCH3
Cl
Cl
CH2CH3


1022.
OCF3
Cl
Cl
CH2CH3


1023.
CH2CH3
Cl
Cl
CH2CH3


1024.
H
H
Br
CH2CH3


1025.
F
H
Br
CH2CH3


1026.
Cl
H
Br
CH2CH3


1027.
Br
H
Br
CH2CH3


1028.
I
H
Br
CH2CH3


1029.
CN
H
Br
CH2CH3


1030.
CH3
H
Br
CH2CH3


1031.
CF3
H
Br
CH2CH3


1032.
OCH3
H
Br
CH2CH3


1033.
OCF3
H
Br
CH2CH3


1034.
CH2CH3
H
Br
CH2CH3


1035.
H
F
Br
CH2CH3


1036.
F
F
Br
CH2CH3


1037.
Cl
F
Br
CH2CH3


1038.
Br
F
Br
CH2CH3


1039.
I
F
Br
CH2CH3


1040.
CN
F
Br
CH2CH3


1041.
CH3
F
Br
CH2CH3


1042.
CF3
F
Br
CH2CH3


1043.
OCH3
F
Br
CH2CH3


1044.
OCF3
F
Br
CH2CH3


1045.
CH2CH3
F
Br
CH2CH3


1046.
H
Cl
Br
CH2CH3


1047.
F
Cl
Br
CH2CH3


1048.
Cl
Cl
Br
CH2CH3


1049.
Br
Cl
Br
CH2CH3


1050.
I
Cl
Br
CH2CH3


1051.
CN
Cl
Br
CH2CH3


1052.
CH3
Cl
Br
CH2CH3


1053.
CF3
Cl
Br
CH2CH3


1054.
OCH3
Cl
Br
CH2CH3


1055.
OCF3
Cl
Br
CH2CH3


1056.
CH2CH3
Cl
Br
CH2CH3


1057.
H
H
I
CH2CH3


1058.
F
H
I
CH2CH3


1059.
Cl
H
I
CH2CH3


1060.
Br
H
I
CH2CH3


1061.
I
H
I
CH2CH3


1062.
CN
H
I
CH2CH3


1063.
CH3
H
I
CH2CH3


1064.
CF3
H
I
CH2CH3


1065.
OCH3
H
I
CH2CH3


1066.
OCF3
H
I
CH2CH3


1067.
CH2CH3
H
I
CH2CH3


1068.
H
F
I
CH2CH3


1069.
F
F
I
CH2CH3


1070.
Cl
F
I
CH2CH3


1071.
Br
F
I
CH2CH3


1072.
I
F
I
CH2CH3


1073.
CN
F
I
CH2CH3


1074.
CH3
F
I
CH2CH3


1075.
CF3
F
I
CH2CH3


1076.
OCH3
F
I
CH2CH3


1077.
OCF3
F
I
CH2CH3


1078.
CH2CH3
F
I
CH2CH3


1079.
H
Cl
I
CH2CH3


1080.
F
Cl
I
CH2CH3


1081.
Cl
Cl
I
CH2CH3


1082.
Br
Cl
I
CH2CH3


1083.
I
Cl
I
CH2CH3


1084.
CN
Cl
I
CH2CH3


1085.
CH3
Cl
I
CH2CH3


1086.
CF3
Cl
I
CH2CH3


1087.
OCH3
Cl
I
CH2CH3


1088.
OCF3
Cl
I
CH2CH3


1089.
CH2CH3
Cl
I
CH2CH3


1090.
H
H
CN
CH2CH3


1091.
F
H
CN
CH2CH3


1092.
Cl
H
CN
CH2CH3


1093.
Br
H
CN
CH2CH3


1094.
I
H
CN
CH2CH3


1095.
CN
H
CN
CH2CH3


1096.
CH3
H
CN
CH2CH3


1097.
CF3
H
CN
CH2CH3


1098.
OCH3
H
CN
CH2CH3


1099.
OCF3
H
CN
CH2CH3


1100.
CH2CH3
H
CN
CH2CH3


1101.
H
F
CN
CH2CH3


1102.
F
F
CN
CH2CH3


1103.
Cl
F
CN
CH2CH3


1104.
Br
F
CN
CH2CH3


1105.
I
F
CN
CH2CH3


1106.
CN
F
CN
CH2CH3


1107.
CH3
F
CN
CH2CH3


1108.
CF3
F
CN
CH2CH3


1109.
OCH3
F
CN
CH2CH3


1110.
OCF3
F
CN
CH2CH3


1111.
CH2CH3
F
CN
CH2CH3


1112.
H
Cl
CN
CH2CH3


1113.
F
Cl
CN
CH2CH3


1114.
Cl
Cl
CN
CH2CH3


1115.
Br
Cl
CN
CH2CH3


1116.
I
Cl
CN
CH2CH3


1117.
CN
Cl
CN
CH2CH3


1118.
CH3
Cl
CN
CH2CH3


1119.
CF3
Cl
CN
CH2CH3


1120.
OCH3
Cl
CN
CH2CH3


1121.
OCF3
Cl
CN
CH2CH3


1122.
CH2CH3
Cl
CN
CH2CH3


1123.
H
H
CH3
CH2CH3


1124.
F
H
CH3
CH2CH3


1125.
Cl
H
CH3
CH2CH3


1126.
Br
H
CH3
CH2CH3


1127.
I
H
CH3
CH2CH3


1128.
CN
H
CH3
CH2CH3


1129.
CH3
H
CH3
CH2CH3


1130.
CF3
H
CH3
CH2CH3


1131.
OCH3
H
CH3
CH2CH3


1132.
OCF3
H
CH3
CH2CH3


1133.
CH2CH3
H
CH3
CH2CH3


1134.
H
F
CH3
CH2CH3


1135.
F
F
CH3
CH2CH3


1136.
Cl
F
CH3
CH2CH3


1137.
Br
F
CH3
CH2CH3


1138.
I
F
CH3
CH2CH3


1139.
CN
F
CH3
CH2CH3


1140.
CH3
F
CH3
CH2CH3


1141.
CF3
F
CH3
CH2CH3


1142.
OCH3
F
CH3
CH2CH3


1143.
OCF3
F
CH3
CH2CH3


1144.
CH2CH3
F
CH3
CH2CH3


1145.
H
Cl
CH3
CH2CH3


1146.
F
Cl
CH3
CH2CH3


1147.
Cl
Cl
CH3
CH2CH3


1148.
Br
Cl
CH3
CH2CH3


1149.
I
Cl
CH3
CH2CH3


1150.
CN
Cl
CH3
CH2CH3


1151.
CH3
Cl
CH3
CH2CH3


1152.
CF3
Cl
CH3
CH2CH3


1153.
OCH3
Cl
CH3
CH2CH3


1154.
OCF3
Cl
CH3
CH2CH3


1155.
CH2CH3
Cl
CH3
CH2CH3









Compounds of formula I.1., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.1.1-I.1.1155, are particularly preferred:




embedded image


Compounds of formula I.2., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.2.1-I.2.1155, are particularly preferred:




embedded image


Compounds of formula I.3., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.3.1-I.3.1155, are particularly preferred:




embedded image


Compounds of formula I.4., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.4.1-I.4.1155, are particularly preferred:




embedded image


Compounds of formula I.5., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.5.1-I.5.1155, are particularly preferred:




embedded image


Compounds of formula I.6., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.6.1-I.6.1155, are particularly preferred:




embedded image


Compounds of formula I.7., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.7.1-I.7.1155, are particularly preferred:




embedded image


Compounds of formula I.8., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.8.1-I.8.1155, are particularly preferred:




embedded image


Compounds of formula I.9., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.9.1-I.9.1155, are particularly preferred:




embedded image


Compounds of formula I.10., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.10.1-I.10.1155, are particularly preferred:




embedded image


Compounds of formula I.11., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.11.1-I.11.1155, are particularly preferred:




embedded image


Compounds of formula I.12., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.12.1-I.12.1155, are particularly preferred:




embedded image


Compounds of formula I.13., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.13.1-I.13.1155, are particularly preferred:




embedded image


Compounds of formula I.14., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.14.1-I.14.1155, are particularly preferred:




embedded image


Compounds of formula I.15., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.15.1-I.15.1155, are particularly preferred:




embedded image


Compounds of formula I.16., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.16.1-I.16.1155, are particularly preferred:




embedded image


Compounds of formula I.17., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.17.1-I.17.1155, are particularly preferred:




embedded image


Compounds of formula I.18., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.18.1-I.18.1155, are particularly preferred:




embedded image


Compounds of formula I.19., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.19.1-I.19.1155, are particularly preferred:




embedded image


Compounds of formula I.20., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.20.1-I.20.1155, are particularly preferred:




embedded image


Compounds of formula I.21., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.21.1-I.21.1155, are particularly preferred:




embedded image


Compounds of formula I.22., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.22.1-I.22.1155, are particularly preferred:




embedded image


Compounds of formula I.23., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.23.1-I.23.1155, are particularly preferred:




embedded image


Compounds of formula I.24., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.24.1-I.24.1155, are particularly preferred:




embedded image


Compounds of formula I.25., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.25.1-I.25.1155, are particularly preferred:




embedded image


Compounds of formula I.26., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.26.1-I.26.1155, are particularly preferred:




embedded image


Compounds of formula I.27., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.27.1-I.27.1155, are particularly preferred:




embedded image


Compounds of formula I.28., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.28.1-I.28.1155, are particularly preferred:




embedded image


Compounds of formula I.29., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.29.1-I.29.1155, are particularly preferred:




embedded image


Compounds of formula I.30., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.30.1-I.30.1155, are particularly preferred:




embedded image


Compounds of formula I.31., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.31.1-I.31.1155, are particularly preferred:




embedded image


Compounds of formula I.32., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.32.1-I.32.1155, are particularly preferred:




embedded image


Compounds of formula I.33., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.33.1-I.33.1155, are particularly preferred:




embedded image


Compounds of formula I.34., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.34.1-I.34.1155, are particularly preferred:




embedded image


Compounds of formula I.35., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.35.1-I.35.1155, are particularly preferred:




embedded image


Compounds of formula I.36., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.36.1-I.36.1155, are particularly preferred:




embedded image


Compounds of formula I.37., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.37.1-I.37.1155, are particularly preferred:




embedded image


Compounds of formula I.38., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8 and R9 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.38.1-I.38.1155, are particularly preferred:




embedded image


Compounds of formula I.39., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.39.1-I.39.1155, are particularly preferred:




embedded image


Compounds of formula I.40., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.40.1-I.40.1155, are particularly preferred:




embedded image


Compounds of formula I.41., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.41.1-I.41.1155, are particularly preferred:




embedded image


Compounds of formula I.42., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.42.1-I.42.1155, are particularly preferred:




embedded image


Compounds of formula I.43., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.43.1-I.43.1155, are particularly preferred:




embedded image


Compounds of formula I.44., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.44.1-I.44.1155, are particularly preferred:




embedded image


Compounds of formula I.45., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.45.1-I.45.1155, are particularly preferred:




embedded image


Compounds of formula I.46., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.46.1-I.46.1155, are particularly preferred:




embedded image


Compounds of formula I.47., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.47.1-I.47.1155, are particularly preferred:




embedded image


Compounds of formula I.48., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.48.1-I.48.1155, are particularly preferred:




embedded image


Compounds of formula I.49., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.49.1-I.49.1155, are particularly preferred:




embedded image


Compounds of formula I.50., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.50.1-I.50.1155, are particularly preferred:




embedded image


Compounds of formula I.51., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.51.1-I.51.1155, are particularly preferred:




embedded image


Compounds of formula I.52., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.52.1-I.52.1155, are particularly preferred:




embedded image


Compounds of formula I.53., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.53.1-I.53.1155, are particularly preferred:




embedded image


Compounds of formula I.54., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.54.1-I.54.1155, are particularly preferred:




embedded image


Compounds of formula I.55., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.55.1-I.55.1155, are particularly preferred:




embedded image


Compounds of formula I.56., wherein W1 is —O—, W2 is —CR9R10—, R1, R2, R6, R8, R9 and R10 are hydrogen, and R3, R4, R5 and R7 have the meanings as defined lines in 1 to 1155 of Table 1 above, i.e. individual compounds I.56.1-I.56.1155, are particularly preferred:




embedded image


The compounds of formula (I) according to the invention can be prepared by standard processes of organic chemistry, for example by the following processes:




embedded image


The compounds of formula (I) can be prepared according to methods or in analogy to methods that are described in the prior art. The synthesis takes advantage of starting materials that are commercially available or may be prepared according to conventional procedures starting from readily available compounds.


Compounds of the formula (I) can be prepared from the carboxylic acids (III) and commercially available amines (II) using an organic base and a coupling reagent. Thus, compounds of formula (I) can be synthesized from the corresponding carboxylic acids (1 eq.) using a coupling reagent (1-2 eq.), for example T3P (propanephosphonic acid anhydride) or HATU (O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorphosphate), an organic base (1-3 eq.) and the amines (II) (1-3 eq.). The reaction is typically carried out in an organic solvent. Preferably an aprotic organic solvent is used. Most preferably tetrahydrofuran (THF), N,N-dimethylformamide (DMF) or acetonitrile (ACN) are used. The reaction is carried out at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Preferably the organic base is triethylamine or N,N-diisopropylethylamine.




embedded image


The carboxylic acids (III) can be prepared from the corresponding esters (IV) (wherein RP is alkyl or benzyl). If RP is alkyl, esters (IV) may be cleaved using aqueous alkali metal hydroxides. Preferably lithium hydroxide, sodium hydroxide or potassium hydroxide (1-2 eq.) are employed. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably the organic solvent is THF, methanol or acetonitrile. The reaction is carried out at temperatures between 0° C. and 100° C. Preferably the reaction is carried at room temperature. If Rp is benzyl in (IV), then the ester may be cleaved using palladium on charcoal (0.001-1 eq.) as catalyst and hydrogen gas at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Typically, an organic solvent is employed. Preferably THF, methanol or ethanol are employed.




embedded image


The aryldihydrofurane (IV_A), wherein W1 is —O— and W2 is —CR9R10—, can be prepared from the corresponding unsubstituted aryldihydrofurane (V), which can be prepared according to the literature procedure J. Org. Chem. 1973, 38, 2319-2328, by deprotonation with an appropriate base and employing a commercially available electrophile. Preferably alkali amides or alkali hydrides (1-4 eq.) are used as a base. In particular, lithium bis(trimethylsilyl)amide or lithium diisopropylamide (3 eq.) are employed. As the corresponding electrophile preferably alkyl halides (4-6 eq.) are employed. The reaction is typically carried out in an aprotic organic solvent. Preferably the organic solvent is THF or diethyl ether. The reaction is carried out at temperatures between −78° C. and room temperature. Preferably the reaction is carried at 0° C.




embedded image


Alternatively, the aryldihydrofurane (IV_A) can be prepared from the corresponding alkenyl halide by palladium-catalyzed cross coupling reaction with a commercially available organometallic compound. Preferably alkenyl bromide of the formula (VI) is employed. Preferably commercially available arylboronic acids (Rs is hydroxyl), aryl boronic esters (Rs is alkoxy), potassium trifluoroborates (Rs is fluor and potassium fluoride adduct) or arylboranes (Rs is alkyl) of the formula (VII) are employed in a Suzuki cross coupling. In particular, aryl boronic acid (Rs2 is hydroxyl) or aryl boronic acid pinacol ester (Rs2 is pinacol) are used. The reaction is typically carried out with catalytic amounts of a palladium(II) salt. Preferably, [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (CAS: 72287-26-4) is used in equivalents ranging from 1 to 10 mol %. The reaction is typically carried out in the presence of an inorganic base. Preferably, alkali or earth alkali hydroxides or carbonates are used. In particular, sodium hydroxide or cesium carbonate are employed. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably the organic solvent is THF, toluene or benzene. The reaction is carried out at elevated temperatures between room temperature and 110° C.


Preferably the reaction is carried out under refluxing conditions.




embedded image


The alkenyl bromide with the formula VI can be prepared from the corresponding dihydrofurane, which can be prepared according to the literature procedure Tetrahedron 2003, 59, 1389-1394, by bromination followed by elimination with a suitable base. Preferably, commercially available bromination reagents are employed. In particular, bromine (CAS: 7726-95-6) is used. Preferably, commercially available organic bases are employed. In particular, non-nucleophilic bases such as diazabicyclic compounds are used. In particular, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, CAS: 6674-22-2) or 1,5-diazabicyclo[4.3.0]non-5-ene (DBN, CAS: 3001-72-7) are employed. The reaction is typically carried out in non-protic organic solvents. Preferably, the organic solvent is halogenated. In particular, dichloromethane is employed as the solvent. The reaction is carried out under cryogenic conditions between −100 and 0° C. Preferably the reaction is carried out at −78° C.




embedded image


The enone of the formula IV_B (wherein W1 is —C(O)—, W2 is —CR9R10— and RP is alkyl) can be prepared from the corresponding alkenyl boronic acid pinacol ester (IX) by intramolecular rhodium-catalyzed cyclization as described in Org. Lett. 2006, 8, 1419-1422. Preferably, bis-(1,5-cyclooctadiene)-dirhodium(I)-dichloride (CAS: 12092-47-6) is employed as the catalyst in quantities ranging from 1 to 10 mol %. The reaction is typically carried out in the presence of a ligand bearing phosphor atoms in equimolar amounts to the used rhodium. Preferably, bidentate phosphine ligands are used. In particular, 1,4-bis(diphenylphosphino)-butane (dppb, CAS: 7688-25-7). The reaction is typically carried out in the presence of an inorganic base. Preferably, alkali or earth alkali carbonates are used. In particular, cesium carbonate is employed. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably, the organic solvents are 1,4-dioxane, THF, diethyl ether. The reaction is carried out at elevated temperatures between room temperature and 110° C. Preferably, the reaction is carried out at 90° C.




embedded image


The alkenyl boronic acid pinacol ester of the formula IX can be prepared from the corresponding aryl iodide (X), the allenyl boronic pinacol acid ester (XI) and the malonic acid (XII) in a three-component palladium-catalyzed addition as described in Org. Lett. 2006, 8, 1419-1422. Preferably, palladium catalysts with an oxidation state of zero are employed. In particular, bis(dibenzylideneacetone)palladium(0) (Pd(dba)2 CAS: 32005-36-0), tris(dibenzylidenaceton)-dipalladium(0) (Pd2(dba)3, CAS: 51364-51-3) or its chloroform complex, tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct (Pd2(dba)3, CAS: 52522-40-4) are employed as catalysts. The reaction is typically carried out in the presence of a ligand bearing phosphor atoms in twice as many equivalents to the used palladium. Preferably, monodentate phosphine ligands are used. In particular, tris(p-trifluoromethylphenyl)-phosphine (CAS: 13406-29-6). The reaction is typically carried out in an organic solvent. Preferably, the organic solvent is toluene or benzene. The reaction is carried out at elevated temperatures between room temperature and 110° C. Preferably, the reaction is carried out at 80° C.




embedded image


In analogy to the synthesis of compound IV_B, the arylenone of the formula IV_C (wherein W1 is —CR9R10—, W2 is —C(O)— and RP is alkyl) can be prepared from the corresponding alkenyl halide by palladium-catalyzed cross coupling reaction with a commercially available organometallic compound. Preferably alkenyl bromide of the formula (XIV) are employed. Preferably commercially available arylboronic acids (Rs is hydroxyl), aryl boronic esters (Rs is alkoxy), potassium trifluoroborates (Rs is fluor including potassium fluoride) and arylboranes (Rs is alkyl) of the formula (VII) are employed in a Suzuki cross coupling. In particular, aryl boronic acid (Rs is hydroxyl) and aryl boronic acid pinacol ester (Rs2 is pinacol) are used. The reaction is typically carried out with catalytic amounts of a palladium(II) salt. Preferably, [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (CAS: 72287-26-4) is used in equivalents ranging from 1 to 10 mol %. The reaction is typically carried out in the presence of an inorganic base. Preferably, alkali or earth alkali hydroxides or carbonates are used. In particular, sodium hydroxide or cesium carbonate are employed. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably the organic solvent is THF, toluene or benzene. The reaction is carried out at elevated temperatures between room temperature and 110° C. Preferably the reaction is carried out under refluxing conditions.


The aryl pentene IV_D, wherein W1 is —CR9R10— and W2 is —CR9R10—, can be prepared according to the procedures described in J. Am. Chem. Soc. 2012, 134, 10773-10776 and Angew. Chem. Int. Ed. 2018, 57, 2721-2725.


To widen the spectrum of action, the compounds of formula (I) may be mixed with many representatives of other herbicidal or growth-regulating active ingredient groups and then applied concomitantly. Suitable components for combinations are, for example, herbicides from the classes of the acetamides, amides, aryloxyphenoxypropionates, benzamides, benzofuran, benzoic acids, benzothiadiazinones, bipyridylium, carbamates, chloroacetamides, chlorocarboxylic acids, cyclohexanediones, dinitroanilines, dinitrophenol, diphenyl ether, glycines, imidazolinones, isoxazoles, isoxazolidinones, nitriles, N-phenylphthalimides, oxadiazoles, oxazolidinediones, oxyacetamides, phenoxycarboxylic acids, phenylcarbamates, phenylpyrazoles, phenylpyrazolines, phenylpyridazines, phosphinic acids, phosphoroamidates, phosphorodithioates, phthalamates, pyrazoles, pyridazinones, pyridines, pyridinecarboxylic acids, pyridinecarboxamides, pyrimidinediones, pyrimidinyl(thio)benzoates, quinolinecarboxylic acids, semicarbazones, sulfonylaminocarbonyltriazolinones, sulfonylureas, tetrazolinones, thiadiazoles, thiocarbamates, triazines, triazinones, triazoles, triazolinones, triazolocarboxamides, triazolopyrimidines, triketones, uracils, ureas.


It may furthermore be beneficial to apply the compounds of formula (I) alone or in combination with other herbicides, or else in the form of a mixture with other crop protection agents, for example together with agents for controlling pests or phytopathogenic fungi or bacteria. Also of interest is the miscibility with mineral salt solutions, which are employed for treating nutritional and trace element deficiencies. Other additives such as non-phytotoxic oils and oil concentrates may also be added.


In one embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) (compound A or component A) and at least one further active compound selected from herbicides B (compound B), preferably herbicides B of class b1) to b15), and safeners C (compound C).


In another embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) and at least one further active compound B (herbicide B).


Examples of herbicides B which can be used in combination with the compounds A of formula (I) according to the present invention are:

    • b1) from the group of the lipid biosynthesis inhibitors:
    • ACC-herbicides such as alloxydim, alloxydim-sodium, butroxydim, clethodim, clodinafop, clodinafop-propargyl, cycloxydim, cyhalofop, cyhalofop-butyl, diclofop, diclofop-methyl, fenoxaprop, fenoxaprop-ethyl, fenoxaprop-P, fenoxaprop-P-ethyl, fluazifop, fluazifop-butyl, fluazifop-P, fluazifop-P-butyl, haloxyfop, haloxyfop-methyl, haloxyfop-P, haloxyfop-P-methyl, metamifop, pinoxaden, profoxydim, propaquizafop, quizalofop, quizalofop-ethyl, quizalofop-tefuryl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, sethoxydim, tepraloxydim, tralkoxydim, 4-(4′-Chloro-4-cyclopropyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1312337-72-6); 4-(2′,4′-Dichloro-4-cyclopropyl[1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1312337-45-3); 4-(4′-Chloro-4-ethyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1033757-93-5); 4-(2′,4′-Dichloro-4-ethyl[1,1′-biphenyl]-3-yl)-2,2,6,6-tetramethyl-2H-pyran-3,5(4H,6H)-dione (CAS 1312340-84-3); 5-(Acetyloxy)-4-(4′-chloro-4-cyclopropyl-2′-fluoro[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312337-48-6); 5-(Acetyloxy)-4-(2′,4′-dichloro-4-cyclopropyl-[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one; 5-(Acetyloxy)-4-(4′-chloro-4-ethyl-2′-fluoro[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312340-82-1); 5-(Acetyloxy)-4-(2′,4′-dichloro-4-ethyl[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1033760-55-2); 4-(4′-Chloro-4-cyclopropyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312337-51-1); 4-(2′,4′-Dichloro-4-cyclopropyl-[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester; 4-(4′-Chloro-4-ethyl-2′-fluoro[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312340-83-2); 4-(2′,4′-Dichloro-4-ethyl[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1033760-58-5); and non ACC herbicides such as benfuresate, butylate, cycloate, dalapon, dimepiperate, EPTC, esprocarb, ethofumesate, flupropanate, molinate, orbencarb, pebulate, prosulfocarb, TCA, thiobencarb, tiocarbazil, triallate and vernolate;
    • b2) from the group of the ALS inhibitors:
    • sulfonylureas such as amidosulfuron, azimsulfuron, bensulfuron, bensulfuron-methyl, chlorimuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron, ethametsulfuron-methyl, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, flupyrsulfuron-methyl-sodium, foramsulfuron, halosulfuron, halosulfuron-methyl, imazosulfuron, iodosulfuron, iodosulfuron-methyl-sodium, iofensulfuron, iofensulfuron-sodium, mesosulfuron, metazosulfuron, metsulfuron, metsulfuron-methyl, nicosulfuron, orthosulfamuron, oxasulfuron, primisulfuron, primisulfuron-methyl, propyrisulfuron, prosulfuron, pyrazosulfuron, pyrazosulfuron-ethyl, rimsulfuron, sulfometuron, sulfometuron-methyl, sulfosulfuron, thifensulfuron, thifensulfuron-methyl, triasulfuron, tribenuron, tribenuron-methyl, trifloxysulfuron, triflusulfuron, triflusulfuron-methyl and tritosulfuron,
    • imidazolinones such as imazamethabenz, imazamethabenz-methyl, imazamox, imazapic, imazapyr, imazaquin and imazethapyr, triazolopyrimidine herbicides and sulfonanilides such as cloransulam, cloransulam-methyl, diclosulam, flumetsulam, florasulam, metosulam, penoxsulam, pyrimisulfan and pyroxsulam,
    • pyrimidinylbenzoates such as bispyribac, bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac, pyriminobac-methyl, pyrithiobac, pyrithiobac-sodium, 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]-benzoic acid-1-methylethyl ester (CAS 420138-41-6), 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]-benzoic acid propyl ester (CAS 420138-40-5), N-(4-bromophenyl)-2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzenemethanamine (CAS 420138-01-8),
    • sulfonylaminocarbonyl-triazolinone herbicides such as flucarbazone, flucarbazone-sodium, propoxycarbazone, propoxycarbazone-sodium, thiencarbazone and thiencarbazone-methyl; and triafamone;
    • among these, a preferred embodiment of the invention relates to those compositions comprising at least one imidazolinone herbicide;
    • b3) from the group of the photosynthesis inhibitors:
    • amicarbazone, inhibitors of the photosystem II, e.g. 1-(6-tert-butylpyrimidin-4-yl)-2-hydroxy-4-methoxy-3-methyl-2H-pyrrol-5-one (CAS 1654744-66-7), 1-(5-tert-butylisoxazol-3-yl)-2-hydroxy-4-methoxy-3-methyl-2H-pyrrol-5-one (CAS 1637455-12-9), 1-(5-tert-butylisoxazol-3-yl)-4-chloro-2-hydroxy-3-methyl-2H-pyrrol-5-one (CAS 1637453-94-1), 1-(5-tert-butyl-1-methyl-pyrazol-3-yl)-4-chloro-2-hydroxy-3-methyl-2H-pyrrol-5-one (CAS 1654057-29-0), 1-(5-tert-butyl-1-methyl-pyrazol-3-yl)-3-chloro-2-hydroxy-4-methyl-2H-pyrrol-5-one (CAS 1654747-80-4), 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one; (CAS 2023785-78-4), 4-hydroxy-1,5-dimethyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 2023785-79-5), 5-ethoxy-4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 1701416-69-4), 4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 1708087-22-2), 4-hydroxy-1,5-dimethyl-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]imidazolidin-2-one (CAS 2023785-80-8), 1-(5-tert-butylisoxazol-3-yl)-4-ethoxy-5-hydroxy-3-methyl-imidazolidin-2-one (CAS 1844836-64-1), triazine herbicides, including of chlorotriazine, triazinones, triazindiones, methylthiotriazines and pyridazinones such as ametryn, atrazine, chloridazone, cyanazine, desmetryn, dimethametryn, hexazinone, metribuzin, prometon, prometryn, propazine, simazine, simetryn, terbumeton, terbuthylazin, terbutryn and trietazin, aryl urea such as chlorobromuron, chlorotoluron, chloroxuron, dimefuron, diuron, fluometuron, isoproturon, isouron, linuron, metamitron, methabenzthiazuron, metobenzuron, metoxuron, monolinuron, neburon, siduron, tebuthiuron and thiadiazuron, phenyl carbamates such as desmedipham, karbutilat, phenmedipham, phenmedipham-ethyl, nitrile herbicides such as bromofenoxim, bromoxynil and its salts and esters, ioxynil and its salts and esters, uraciles such as bromacil, lenacil and terbacil, and bentazon and bentazon-sodium, pyridate, pyridafol, pentanochlor and propanil and inhibitors of the photosystem I such as diquat, diquat-dibromide, paraquat, paraquat-dichloride and paraquat-dimetilsulfate. Among these, a preferred embodiment of the invention relates to those compositions comprising at least one aryl urea herbicide. Among these, likewise a preferred embodiment of the invention relates to those compositions comprising at least one triazine herbicide. Among these, likewise a preferred embodiment of the invention relates to those compositions comprising at least one nitrile herbicide;
    • b4) from the group of the protoporphyrinogen-IX oxidase inhibitors:
    • acifluorfen, acifluorfen-sodium, azafenidin, bencarbazone, benzfendizone, bifenox, butafenacil, carfentrazone, carfentrazone-ethyl, chlomethoxyfen, chlorphthalim, cinidon-ethyl, cyclopyranil, fluazolate, flufenpyr, flufenpyr-ethyl, flumiclorac, flumiclorac-pentyl, flumioxazin, fluoroglycofen, fluoroglycofen-ethyl, fluthiacet, fluthiacet-methyl, fomesafen, halosafen, lactofen, oxadiargyl, oxadiazon, oxyfluorfen, pentoxazone, profluazol, pyraclonil, pyraflufen, pyraflufen-ethyl, saflufenacil, sulfentrazone, thidiazimin, tiafenacil, trifludimoxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate (CAS 353292-31-6; S-3100), N-ethyl-3-(2,6-dichloro-4-trifluoro-methylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452098-92-9), N-tetrahydrofurfuryl-3-(2,6-dichloro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 915396-43-9), N-ethyl-3-(2-chloro-6-fluoro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452099-05-7), N-tetrahydrofurfuryl-3-(2-chloro-6-fluoro-4-trifluoro-methylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452100-03-7), 3-[7-fluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-1,5-dimethyl-6-thioxo-[1,3,5]triazinan-2,4-dione (CAS 451484-50-7), 2-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4,5,6,7-tetrahydro-isoindole-1,3-dione (CAS 1300118-96-0), 1-methyl-6-trifluoromethyl-3-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-1H-pyrimidine-2,4-dione (CAS 1304113-05-0), methyl (E)-4-[2-chloro-5-[4-chloro-5-(difluoromethoxy)-1H-methyl-pyrazol-3-yl]-4-fluoro-phenoxy]-3-methoxy-but-2-enoate (CAS 948893-00-3), and 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)-1H-pyrimidine-2,4-dione (CAS 212754-02-4), 2-[2-chloro-5-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-4-fluorophenoxy]-2-methoxy-acetic acid methyl ester (CAS 1970221-16-9), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-acetic acid methyl ester (CAS 2158274-96-3), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy] acetic acid ethyl ester (CAS 158274-50-9), methyl 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]acetate (CAS 2271389-22-9), ethyl 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]acetate (CAS 2230679-62-4), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-acetic acid methyl ester (CAS 2158275-73-9), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy] acetic acid ethyl ester (CAS 2158274-56-5), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-N-(methylsulfonyl)-acetamide (CAS 2158274-53-2), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-N-(methylsulfonyl)-acetamide (CAS 2158276-22-1);
    • b5) from the group of the bleacher herbicides:
    • PDS inhibitors: beflubutamid, diflufenican, fluridone, flurochloridone, flurtamone, norflurazon, picolinafen, and 4-(3-trifluoromethylphenoxy)-2-(4-trifluoromethylphenyl)pyrimidine (CAS 180608-33-7), HPPD inhibitors: benzobicyclon, benzofenap, bicyclopyrone, clomazone, fenquinotrione, isoxaflutole, mesotrione, oxotrione (CAS 1486617-21-3), pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, tolpyralate, topramezone, bleacher, unknown target: aclonifen, amitrole flumeturon 2-chloro-3-methylsulfanyl-N-(1-methyltetrazol-5-yl)-4-(trifluoromethyl)benzamide (CAS 1361139-71-0), bixlozone and 2-(2,5-dichlorophenyl)methyl-4,4-dimethyl-3-isoxazolidinone (CAS 81778-66-7);
    • b6) from the group of the EPSP synthase inhibitors:
    • glyphosate, glyphosate-isopropylammonium, glyposate-potassium and glyphosate-trimesium (sulfosate);
    • b7) from the group of the glutamine synthase inhibitors:
    • bilanaphos (bialaphos), bilanaphos-sodium, glufosinate, glufosinate-P and glufosinate-ammonium;
    • b8) from the group of the DHP synthase inhibitors:
    • asulam;
    • b9) from the group of the mitosis inhibitors:
    • compounds of group K1: dinitroanilines such as benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin, oryzalin, pendimethalin, prodiamine and trifluralin, phosphoramidates such as amiprophos, amiprophos-methyl, and butamiphos, benzoic acid herbicides such as chlorthal, chlorthal-dimethyl, pyridines such as dithiopyr and thiazopyr, benzamides such as propyzamide and tebutam; compounds of group K2: carbetamide, chlorpropham, flamprop, flamprop-isopropyl, flamprop-methyl, flamprop-M-isopropyl, flamprop-M-methyl and propham; among these, compounds of group K1, in particular dinitroanilines are preferred;
    • b10) from the group of the VLCFA inhibitors:
    • chloroacetamides such as acetochlor, alachlor, amidochlor, butachlor, dimethachlor, dimethenamid, dimethenamid-P, metazachlor, metolachlor, metolachlor-S, pethoxamid, pretilachlor, propachlor, propisochlor and thenylchlor, oxyacetanilides such as flufenacet and mefenacet, acetanilides such as diphenamid, naproanilide, napropamide and napropamide-M, tetrazolinones such fentrazamide, and other herbicides such as anilofos, cafenstrole, fenoxasulfone, ipfencarbazone, piperophos, pyroxasulfone and isoxazoline compounds of the formulae II.1, II.2, II.3, II.4, II.5, II.6, II.7, II.8 and II.9




embedded image


embedded image




    • the isoxazoline compounds of the formula (II) are known in the art, e.g. from WO 2006/024820 WO 2006/037945, WO 2007/071900 and WO 2007/096576;

    • among the VLCFA inhibitors, preference is given to chloroacetamides and oxyacetamides;

    • b11) from the group of the cellulose biosynthesis inhibitors:

    • chlorthiamid, dichlobenil, flupoxam, indaziflam, isoxaben, triaziflam and 1-cyclohexyl-5-pentafluorphenyloxy-14-[1,2,4,6]thiatriazin-3-ylamine (CAS 175899-01-1);

    • b12) from the group of the decoupler herbicides:

    • dinoseb, dinoterb and DNOC and its salts;

    • b13) from the group of the auxinic herbicides:

    • 2,4-D and its salts and esters such as clacyfos, 2,4-DB and its salts and esters, aminocyclopyrachlor and its salts and esters, aminopyralid and its salts such as aminopyralid-dimethylammonium, aminopyralid-tris(2-hydroxypropyl)ammonium and its esters, benazolin, benazolin-ethyl, chloramben and its salts and esters, clomeprop, clopyralid and its salts and esters, dicamba and its salts and esters, dichlorprop and its salts and esters, dichlorprop-P and its salts and esters, flopyrauxifen, fluroxypyr, fluroxypyr-butometyl, fluroxypyr-meptyl, halauxifen and its salts and esters (CAS 943832-60-8); MCPA and its salts and esters, MCPA-thioethyl, MCPB and its salts and esters, mecoprop and its salts and esters, mecoprop-P and its salts and esters, picloram and its salts and esters, quinclorac, quinmerac, TBA (2,3,6) and its salts and esters, triclopyr and its salts and esters, florpyrauxifen, florpyrauxifen-benzyl (CAS 1390661-72-9) and 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)picolinic acid (CAS 1629965-65-6);

    • b14) from the group of the auxin transport inhibitors: diflufenzopyr, diflufenzopyr-sodium, naptalam and naptalam-sodium;

    • b15) from the group of the other herbicides: bromobutide, chlorflurenol, chlorflurenol-methyl, cinmethylin, cumyluron, cyclopyrimorate (CAS 499223-49-3) and its salts and esters, dalapon, dazomet, difenzoquat, difenzoquat-metilsulfate, dimethipin, DSMA, dymron, endothal and its salts, etobenzanid, flurenol, flurenol-butyl, flurprimidol, fosamine, fosamine-ammonium, indanofan, maleic hydrazide, mefluidide, metam, methiozolin, methyl azide, methyl bromide, methyl-dymron, methyl iodide, MSMA, oleic acid, oxaziclomefone, pelargonic acid, pyributicarb, quinoclamine tetflupyrolimet, and tridiphane.





Moreover, it may be useful to apply the compounds of formula (I) in combination with safeners. Safeners are chemical compounds which prevent or reduce damage on useful plants without having a major impact on the herbicidal action of the compounds of the formula (I) towards undesired vegetation. They can be applied either before sowings (e.g. on seed treatments, shoots or seedlings) or in the pre-emergence application or post-emergence application of the useful plant. The safeners and the compounds of formula (I) and optionally the herbicides B can be applied simultaneously or in succession.


In another embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) and at least one safener C (component C).


Examples of safeners are e.g. (quinolin-8-oxy)acetic acids, 1-phenyl-5-haloalkyl-1H-1,2,4-triazol-3-carboxylic acids, 1-phenyl-4,5-dihydro-5-alkyl-1H-pyrazol-3,5-dicarboxylic acids, 4,5-dihydro-5,5-diaryl-3-isoxazol carboxylic acids, dichloroacetamides, alpha-oximinophenylacetonitriles, acetophenonoximes, 4,6-dihalo-2-phenylpyrimidines, N-[[4-(aminocarbonyl)phenyl]sulfonyl]-2-benzoic amides, 1,8-naphthalic anhydride, 2-halo-4-(haloalkyl)-5-thiazol carboxylic acids, phosphorthiolates and N-alkyl-O-phenylcarbamates and their agriculturally acceptable salts and their agriculturally acceptable derivatives such amides, esters, and thioesters, provided they have an acid group.


Examples of safener compounds C are benoxacor, cloquintocet, cyometrinil, cyprosulfamide, dichlormid, dicyclonon, dietholate, fenchlorazole, fenclorim, flurazole, fluxofenim, furilazole, isoxadifen, mefenpyr, mephenate, naphthalic anhydride, oxabetrinil, 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (MON4660, CAS 71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (R-29148, CAS 52836-31-4), metcamifen and BPCMS (CAS 54091-06-4).


The active compounds B of groups b1) to b15) and the active compounds C are known herbicides and safeners, see, for example, The Compendium of Pesticide Common Names (http://www.alanwood.net/pesticides/); Farm Chemicals Handbook 2000 volume 86, Meister Publishing Company, 2000; B. Hock, C. Fedtke, R. R. Schmidt, Herbizide [Herbicides], Georg Thieme Verlag, Stuttgart 1995; W. H. Ahrens, Herbicide Handbook, 7th edition, Weed Science Society of America, 1994; and K. K. Hatzios, Herbicide Handbook, Supplement for the 7th edition, Weed Science Society of America, 1998. 2,2,5-Trimethyl-3-(dichloroacetyl)-1,3-oxazolidine [CAS No. 52836-31-4] is also referred to as R-29148. 4-(Dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane [CAS No. 71526-07-3] is also referred to as AD-67 and MON 4660.


The assignment of the active compounds to the respective mechanisms of action is based on current knowledge. If several mechanisms of action apply to one active compound, this substance was only assigned to one mechanism of action.


The invention also relates to formulations comprising at least an auxiliary and at least one compound of formula (I) according to the invention.


A formulation comprises a pesticidally effective amount of a compound of formula (I). The term “effective amount” denotes an amount of the combination or of the compound of formula (I), which is sufficient for controlling undesired vegetation, especially for controlling undesired vegetation in crops (i.e. cultivated plants) and which does not result in a substantial damage to the treated crop plants. Such an amount can vary in a broad range and is dependent on various factors, such as the undesired vegetation to be controlled, the treated crop plants or material, the climatic conditions and the specific compound of formula (I) used.


The compounds of formula (I), their salts, amides, esters or thioesters can be converted into customary types of formulations, e.g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for formulation types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF). These and further formulation types are defined in the “Catalogue of pesticide formulation types and international coding system”, Technical Monograph No. 2, 6th Ed. May 2008, CropLife International.


The formulations are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.


Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetting agents, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.


Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e.g. toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclohexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof.


Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e.g. cellulose, starch; fertilizers, e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e.g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.


Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol. 1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).


Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.


Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinylpyrrolidone, vinylalcohols, or vinylacetate.


Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or polyethyleneamines.


Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the compounds of formula (I) on the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.


Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.


Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones.


Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.


Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.


Suitable colorants (e.g. in red, blue, or green) are pigments of low water solubility and water-soluble dyes. Examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanoferrate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).


Suitable tackifiers or binders are polyvinylpyrrolidons, polyvinylacetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.


Examples for formulation types and their preparation are:


i) Water-Soluble Concentrates (SL, LS)

10-60 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 5-15 wt % wetting agent (e.g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e.g. alcohols) ad 100 wt %. The active substance dissolves upon dilution with water.


ii) Dispersible Concentrates (DC)

5-25 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 1-10 wt % dispersant (e.g. polyvinylpyrrolidone) are dissolved in organic solvent (e.g. cyclohexanone) ad 100 wt %. Dilution with water gives a dispersion.


iii) Emulsifiable Concentrates (EC)


15-70 wt % of compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 5-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %. Dilution with water gives an emulsion.


iv) Emulsions (EW, EO, ES)

5-40 wt % of compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention and 1-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt % water-insoluble organic solvent (e.g. aromatic hydrocarbon). This mixture is introduced into water ad 100 wt % by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion.


v) Suspensions (SC, OD, FS)

In an agitated ball mill, 20-60 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are comminuted with addition of 2-10 wt % dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate), 0.1-2 wt % thickener (e.g. xanthan gum) and water ad 100 wt % to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type formulation up to 40 wt % binder (e.g. polyvinylalcohol) is added.


vi) Water-Dispersible Granules and Water-Soluble Granules (WG, SG)

50-80 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are ground finely with addition of dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt % and prepared as water-dispersible or water-soluble granules by means of technical appliances (e.g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance.


vii) Water-Dispersible Powders and Water-Soluble Powders (WP, SP, WS)


50-80 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are ground in a rotor-stator mill with addition of 1-5 wt % dispersants (e.g. sodium lignosulfonate), 1-3 wt % wetting agents (e.g. alcohol ethoxylate) and solid carrier (e.g. silica gel) ad 100 wt %. Dilution with water gives a stable dispersion or solution of the active substance.


viii) Gel (GW, GF)


In an agitated ball mill, 5-25 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are comminuted with addition of 3-10 wt % dispersants (e.g. sodium lignosulfonate), 1-5 wt % thickener (e.g. carboxymethylcellulose) and water ad 100 wt % to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.


iv) Microemulsion (ME)

5-20 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are added to 5-30 wt % organic solvent blend (e.g. fatty acid dimethylamide and cyclohexanone), 10-25 wt % surfactant blend (e.g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100%. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion.


iv) Microcapsules (CS)

An oil phase comprising 5-50 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 wt % acrylic monomers (e.g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt % of a compound of formula (I) according to the invention, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g. diphenylmethene-4,4′-diisocyanate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). The addition of a polyamine (e.g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1-10 wt %. The wt % relate to the total CS formulation.


ix) Dustable powders (DP, DS)


1-10 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are ground finely and mixed intimately with solid carrier (e.g. finely divided kaolin) ad 100 wt %.


x) Granules (GR, FG)

0.5-30 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention is ground finely and associated with solid carrier (e.g. silicate) ad 100 wt %. Granulation is achieved by extrusion, spray-drying or the fluidized bed.


xi) Ultra-low volume liquids (UL)


1-50 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are dissolved in organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %.


The formulation types i) to xi) may optionally comprise further auxiliaries, such as 0.1-1 wt % bactericides, 5-15 wt % anti-freezing agents, 0.1-1 wt % anti-foaming agents, and 0.1-1 wt % colorants.


The formulations and/or combinations generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of the compounds of formula (I).


The compounds of formula (I) are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).


Solutions for seed treatment (LS), suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC) and gels (GF) are usually employed for the purposes of treatment of plant propagation materials, particularly seeds. The formulations in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40% by weight, in the ready-to-use preparations. (nach unten verschoben)


Methods for applying compounds of formula (I), formulations and/or combinations thereof, on to plant propagation material, especially seeds, include dressing, coating, pelleting, dusting, soaking and in-furrow application methods of the propagation material. Preferably, compounds of formula (I), formulations and/or combinations thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e.g. by seed dressing, pelleting, coating and dusting.


Various types of oils, wetting agents, adjuvants, fertilizer, or micronutrients, and further pesticides (e.g. herbicides, insecticides, fungicides, growth regulators, safeners) may be added to the compounds of formula (I), the formulations and/or the combinations comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the formulations according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1.


The user applies the compounds of formula (I) according to the invention, the formulations and/or the combinations comprising them usually from a pre-dosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the formulation is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the formulation according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.


According to one embodiment, either individual components of the formulation according to the invention or partially premixed components, e.g. components comprising compounds of formula (I) and optionally active substances from the groups B and/or C), may be mixed by the user in a spray tank and further auxiliaries and additives may be added, if appropriate.


In a further embodiment, individual components of the formulation according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank and further auxiliaries may be added, if appropriate.


In a further embodiment, either individual components of the formulation according to the invention or partially premixed components, e.g components comprising compounds of formula (I) and optionally active substances from the groups B and/or C), can be applied jointly (e.g. after tank mix) or consecutively.


The compounds of formula (I), are suitable as herbicides. They are suitable as such, as an appropriate formulation or in combination with at least one further compound selected from the herbicidal active compounds B (component B) and safeners C (component C).


The compounds of formula (I), or the formulations and/or combinations comprising the compounds of formula (I), control undesired vegetation on non-crop areas very efficiently, especially at high rates of application. They act against broad-leaved weeds and grass weeds in crops such as wheat, rice, maize, soya and cotton without causing any significant damage to the crop plants. This effect is mainly observed at low rates of application.


The compounds of formula (I), or the formulations and/or the combinations comprising them, are applied to the plants mainly by spraying the leaves. Here, the application can be carried out using, for example, water as carrier by customary spraying techniques using spray liquor amounts of from about 100 to 1000 l/ha (for example from 300 to 400 l/ha). The compounds of formula (I), or the formulations and/or the combinations comprising them, may also be applied by the low-volume or the ultra-low-volume method, or in the form of microgranules.


Application of the compounds of formula (I), or the formulations and/or the combinations comprising them, can be done before, during and/or after, preferably during and/or after, the emergence of the undesired vegetation.


Application of the compounds of formula (I), or the formulations and/or the combinations can be carried out before or during sowing.


The compounds of formula (I), or the formulations and/or the combinations comprising them, can be applied pre-, post-emergence or pre-plant, or together with the seed of a crop plant. It is also possible to apply the compounds of formula (I), or the formulations and/or the combinations comprising them, by applying seed, pretreated with the compounds of formula (I), or the formulations and/or the combinations comprising them, of a crop plant. If the active ingredients are less well tolerated by certain crop plants, application techniques may be used in which the combinations are sprayed, with the aid of the spraying equipment, in such a way that as far as possible they do not come into contact with the leaves of the sensitive crop plants, while the active ingredients reach the leaves of undesired vegetation growing underneath, or the bare soil surface (post-directed, lay-by).


In a further embodiment, the compounds of formula (I), or the formulations and/or the combinations comprising them, can be applied by treating seed. The treatment of seeds comprises essentially all procedures familiar to the person skilled in the art (seed dressing, seed coating, seed dusting, seed soaking, seed film coating, seed multilayer coating, seed encrusting, seed dripping and seed pelleting) based on the compounds of formula (I), or the formulations and/or the combinations prepared therefrom. Here, the combinations can be applied diluted or undiluted.


The term “seed” comprises seed of all types, such as, for example, corns, seeds, fruits, tubers, seedlings and similar forms. Here, preferably, the term seed describes corns and seeds. The seed used can be seed of the crop plants mentioned above, but also the seed of transgenic plants or plants obtained by customary breeding methods.


When employed in plant protection, the amounts of active substances applied, i.e. the compounds of formula (I), component B and, if appropriate, component C without formulation auxiliaries, are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha and in particular from 0.1 to 0.75 kg per ha.


In another embodiment of the invention, the application rate of the compounds of formula (I), component B and, if appropriate, component C, is from 0.001 to 3 kg/ha, preferably from 0.005 to 2.5 kg/ha and in particular from 0.01 to 2 kg/ha of active substance (a.s.).


In another preferred embodiment of the invention, the rates of application of the compounds of formula (I) according to the present invention (total amount of compounds of formula (I)) are from 0.1 g/ha to 3000 g/ha, preferably 10 g/ha to 1000 g/ha, depending on the control target, the season, the target plants and the growth stage.


In another preferred embodiment of the invention, the application rates of the compounds of formula (I) are in the range from 0.1 g/ha to 5000 g/ha and preferably in the range from 1 g/ha to 2500 g/ha or from 5 g/ha to 2000 g/ha.


In another preferred embodiment of the invention, the application rate of the compounds of formula (I) is 0.1 to 1000 g/ha, preferably 1 to 750 g/ha, more preferably 5 to 500 g/ha.


The required application rates of herbicidal compounds B are generally in the range of from 0.0005 kg/ha to 2.5 kg/ha and preferably in the range of from 0.005 kg/ha to 2 kg/ha or 0.01 kg/ha to 1.5 kg/h of a.s.


The required application rates of safeners C are generally in the range of from 0.0005 kg/ha to 2.5 kg/ha and preferably in the range of from 0.005 kg/ha to 2 kg/ha or 0.01 kg/ha to 1.5 kg/h of a.s.


In treatment of plant propagation materials such as seeds, e.g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seeds) are generally required.


In another embodiment of the invention, to treat the seed, the amounts of active substances applied, i.e. the compounds of formula (I), component B and, if appropriate, component C are generally employed in amounts of from 0.001 to 10 kg per 100 kg of seed.


When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.


In case of combinations according to the present invention it is immaterial whether the compounds of formula (I), and the further component B and/or the component C are formulated and applied jointly or separately.


In the case of separate application, it is of minor importance, in which order the application takes place. It is only necessary, that the compounds of formula (I), and the further component B and/or the component C are applied in a time frame that allows simultaneous action of the active ingredients on the plants, preferably within a time-frame of at most 14 days, in particular at most 7 days.


Depending on the application method in question, the compounds of formula (I), or the formulations and/or combinations comprising them, can additionally be employed in a further number of crop plants for eliminating undesired vegetation. Examples of suitable crops are the following:



Allium cepa, Ananas comosus, Arachis hypogaea, Asparagus officinalis, Avena sativa, Beta vulgaris spec. altissima, Beta vulgaris spec. rapa, Brassica napus var. napus, Brassica napus var. napobrassica, Brassica rapa var. silvestris, Brassica oleracea, Brassica nigra, Camellia sinensis, Carthamus tinctorius, Carya illinoinensis, Citrus limon, Citrus sinensis, Coffea arabica (Coffea canephora, Coffea liberica), Cucumis sativus, Cynodon dactylon, Daucus carota, Elaeis guineensis, Fragaria vesca, Glycine max, Gossypium hirsutum, (Gossypium arboreum, Gossypium herbaceum, Gossypium vitifolium), Helianthus annuus, Hevea brasiliensis, Hordeum vulgare, Humulus lupulus, Ipomoea batatas, Juglans regia, Lens culinaris, Linum usitatissimum, Lycopersicon lycopersicum, Malus spec., Manihot esculenta, Medicago sativa, Musa spec., Nicotiana tabacum (N. rustica), Olea europaea, Oryza sativa, Phaseolus lunatus, Phaseolus vulgaris, Picea abies, Pinus spec., Pistacia vera, Pisum sativum, Prunus avium, Prunus persica, Pyrus communis, Prunus armeniaca, Prunus cerasus, Prunus dulcis and Prunus domestica, Ribes sylvestre, Ricinus communis, Saccharum officinarum, Secale cereale, Sinapis alba, Solanum tuberosum, Sorghum bicolor (S. vulgare), Theobroma cacao, Trifolium pratense, Triticum aestivum, Triticale, Triticum durum, Vicia faba, Vitis vinifera and Zea mays.


Preferred crops are Arachis hypogaea, Beta vulgaris spec. altissima, Brassica napus var. napus, Brassica oleracea, Citrus limon, Citrus sinensis, Coffea arabica (Coffea canephora, Coffea liberica), Cynodon dactylon, Glycine max, Gossypium hirsutum, (Gossypium arboreum, Gossypium herbaceum, Gossypium vitifolium), Helianthus annuus, Hordeum vulgare, Juglans regia, Lens culinaris, Linum usitatissimum, Lycopersicon lycopersicum, Malus spec., Medicago sativa, Nicotiana tabacum (N. rustica), Olea europaea, Oryza sativa, Phaseolus lunatus, Phaseolus vulgaris, Pistacia vera, Pisum sativum, Prunus dulcis, Saccharum officinarum, Secale cereale, Solanum tuberosum, Sorghum bicolor (S. vulgare), Triticale, Triticum aestivum, Triticum durum, Vicia faba, Vitis vinifera and Zea mays.


Especially preferred crops are crops of cereals, corn, soybeans, rice, oilseed rape, cotton, potatoes, peanuts or permanent crops.


The compounds of formula (I) according to the invention, or the formulations and/or combinations comprising them, can also be used in crops which have been modified by mutagenesis or genetic engineering in order to provide a new trait to a plant or to modify an already present trait.


The term “crops” as used herein includes also (crop) plants which have been modified by mutagenesis or genetic engineering in order to provide a new trait to a plant or to modify an already present trait.


Mutagenesis includes techniques of random mutagenesis using X-rays or mutagenic chemicals, but also techniques of targeted mutagenesis, in order to create mutations at a specific locus of a plant genome. Targeted mutagenesis techniques frequently use oligonucleotides or proteins like CRISPR/Cas, zinc-finger nucleases, TALENs or meganucleases to achieve the targeting effect.


Genetic engineering usually uses recombinant DNA techniques to create modifications in a plant genome which under natural circumstances cannot readily be obtained by cross breeding, mutagenesis or natural recombination. Typically, one or more genes are integrated into the genome of a plant in order to add a trait or improve a trait. These integrated genes are also referred to as transgenes in the art, while plant comprising such transgenes are referred to as transgenic plants. The process of plant transformation usually produces several transformation events, which differ in the genomic locus in which a transgene has been integrated. Plants comprising a specific transgene on a specific genomic locus are usually described as comprising a specific “event”, which is referred to by a specific event name. Traits which have been introduced in plants or have been modified include in particular herbicide tolerance, insect resistance, increased yield and tolerance to abiotic conditions, like drought.


Herbicide tolerance has been created by using mutagenesis as well as using genetic engineering. Plants which have been rendered tolerant to acetolactate synthase (ALS) inhibitor herbicides by conventional methods of mutagenesis and breeding comprise plant varieties commercially available under the name Clearfield®. However, most of the herbicide tolerance traits have been created via the use of transgenes.


Herbicide tolerance has been created to glyphosate, glufosinate, 2,4-D, dicamba, oxynil herbicides, like bromoxynil and ioxynil, sulfonylurea herbicides, ALS inhibitor herbicides and 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors, like isoxaflutole and mesotrione.


Transgenes which have been used to provide herbicide tolerance traits comprise: for tolerance to glyphosate: cp4 epsps, epsps grg23ace5, mepsps, 2mepsps, gat4601, gat4621 and goxv247, for tolerance to glufosinate: pat and bar, for tolerance to 2,4-D: aad-1 and aad-12, for tolerance to dicamba: dmo, for tolerance to oxynil herbicies: bxn, for tolerance to sulfonylurea herbicides: zm-hra, csr1-2, gm-hra, S4-HrA, for tolerance to ALS inhibitor herbicides: csr1-2, for tolerance to HPPD inhibitor herbicides: hppdPF, W336 and avhppd-03.


Transgenic corn events comprising herbicide tolerance genes are for example, but not excluding others, DAS40278, MON801, MON802, MON809, MON810, MON832, MON87411, MON87419, MON87427, MON88017, MON89034, NK603, GA21, MZHGOJG, HCEM485, VCO-01981-5, 676, 678, 680, 33121, 4114, 59122, 98140, Bt10, Bt176, CBH-351, DBT418, DLL25, MS3, MS6, MZIR098, T25, TC1507 and TC6275.


Transgenic soybean events comprising herbicide tolerance genes are for example, but not excluding others, GTS 40-3-2, MON87705, MON87708, MON87712, MON87769, MON89788, A2704-12, A2704-21, A5547-127, A5547-35, DP356043, DAS44406-6, DAS68416-4, DAS-81419-2, GU262, SYHTØH2, W62, W98, FG72 and CV127.


Transgenic cotton events comprising herbicide tolerance genes are for example, but not excluding others, 19-51a, 31707, 42317, 81910, 281-24-236, 3006-210-23, BXN10211, BXN10215, BXN10222, BXN10224, MON1445, MON1698, MON88701, MON88913, GHB119, GHB614, LLCotton25, T303-3 and T304-40.


Transgenic canola events comprising herbicide tolerance genes are for example, but not excluding others, MON88302, HCR-1, HCN10, HCN28, HCN92, MS1, MS8, PHY14, PHY23, PHY35, PHY36, RF1, RF2 and RF3.


Insect resistance has mainly been created by transferring bacterial genes for insecticidal proteins to plants. Transgenes which have most frequently been used are toxin genes of Bacillus spec. and synthetic variants thereof, like cry1A, cry1Ab, cry1Ab-Ac, cry1Ac, cry1A.105, cry1F, cry1Fa2, cry2Ab2, cry2Ae, mcry3A, ecry3.1Ab, cry3Bb1, cry34Ab1, cry35Ab1, cry9C, vip3A(a), vip3Aa20. However, also genes of plant origin have been transferred to other plants.


In particular genes coding for protease inhibitors, like CpTI and pinII. A further approach uses transgenes in order to produce double stranded RNA in plants to target and downregulate insect genes. An example for such a transgene is dvsnf7.


Transgenic corn events comprising genes for insecticidal proteins or double stranded RNA are for example, but not excluding others, Bt10, Bt11, Bt176, MON801, MON802, MON809, MON810, M0N863, M0N87411, M0N88017, M0N89034, 33121, 4114, 5307, 59122, TC1507, TC6275, CBH-351, MIR162, DBT418 and MZIR098.


Transgenic soybean events comprising genes for insecticidal proteins are for example, but not excluding others, MON87701, MON87751 and DAS-81419.


Transgenic cotton events comprising genes for insecticidal proteins are for example, but not excluding others, SGK321, MON531, MON757, MON1076, MON15985, 31707, 31803, 31807, 31808, 42317, BNLA-601, Event1, COT67B, COT102, T303-3, T304-40, GFM Cry1A, GK12, MLS 9124, 281-24-236, 3006-210-23, GHB119 and SGK321.


Increased yield has been created by increasing ear biomass using the transgene athb17, being present in corn event MON87403, or by enhancing photosynthesis using the transgene bbx32, being present in the soybean event MON87712.


Crops comprising a modified oil content have been created by using the transgenes: gm-fad2-1, Pj.D6D, Nc.Fad3, fad2-1A and fatb1-A. Soybean events comprising at least one of these genes are: 260-05, MON87705 and MON87769.


Tolerance to abiotic conditions, in particular to tolerance to drought, has been created by using the transgene cspB, comprised by the corn event MON87460 and by using the transgene Hahb-4, comprised by soybean event IND-00410-5.


Traits are frequently combined by combining genes in a transformation event or by combining different events during the breeding process. Preferred combination of traits are herbicide tolerance to different groups of herbicides, insect tolerance to different kind of insects, in particular tolerance to lepidopteran and coleopteran insects, herbicide tolerance with one or several types of insect resistance, herbicide tolerance with increased yield as well as a combination of herbicide tolerance and tolerance to abiotic conditions.


Plants comprising singular or stacked traits as well as the genes and events providing these traits are well known in the art. For example, detailed information as to the mutagenized or integrated genes and the respective events are available from websites of the organizations “International Service for the Acquisition of Agri-biotech Applications (ISAAA)” (http://www.isaaa.org/gmapprovaldatabase) and the “Center for Environmental Risk Assessment (CERA)” (http://cera-gmc.org/GMCropDatabase), as well as in patent applications, like EP3028573 and WO2017/011288.


The use of the compounds of formula (I) or formulations or combinations comprising them according to the invention on crops may result in effects which are specific to a crop comprising a certain gene or event. These effects might involve changes in growth behavior or changed resistance to biotic or abiotic stress factors. Such effects may in particular comprise enhanced yield, enhanced resistance or tolerance to insects, nematodes, fungal, bacterial, mycoplasma, viral or viroid pathogens as well as early vigor, early or delayed ripening, cold or heat tolerance as well as changed amino acid or fatty acid spectrum or content.


Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of ingredients or new ingredients, specifically to improve raw material production, e.g., potatoes that produce increased amounts of amylopectin (e.g. Amflora® potato, BASF SE, Germany).


Furthermore, it has been found that the compounds of formula (I) according to the invention, or the formulations and/or combinations comprising them, are also suitable for the defoliation and/or desiccation of plant parts of crops such as cotton, potato, oilseed rape, sunflower, soybean or field beans, in particular cotton. In this regard, formulations and/or combinations for the desiccation and/or defoliation of crops, processes for preparing these formulations and/or combinations and methods for desiccating and/or defoliating plants using the compounds of formula (I) have been found.


As desiccants, the compounds of formula (I) are particularly suitable for desiccating the above-ground parts of crop plants such as potato, oilseed rape, sunflower and soybean, but also cereals. This makes possible the fully mechanical harvesting of these important crop plants.


Also of economic interest is to facilitate harvesting, which is made possible by concentrating within a certain period of time the dehiscence, or reduction of adhesion to the tree, in citrus fruit, olives and other species and varieties of pernicious fruit, stone fruit and nuts. The same mechanism, i.e. the promotion of the development of abscission tissue between fruit part or leaf part and shoot part of the plants is also essential for the controlled defoliation of useful plants, in particular cotton.


Moreover, a shortening of the time interval in which the individual cotton plants mature leads to an increased fiber quality after harvesting.







A CHEMISTRY EXAMPLES

Chemical bonds, drawn as bars in chemical formulae, indicate the relative stereochemistry on the ring system.


Example 1
Synthesis of ethyl 4-(3,5-difluorophenyl)-2,3-dihydrofuran-2-carboxylate (Inter A)



embedded image


To a mixture of aryl bromide (I) (40 g, 209 mmol) in dimethoxyethane (500 mL) was added compound II (35.2 g, 209 mmol), aq. sat, Na2CO3 (500 mL) and tetrakis(triphenylphosphine)-palladium(0) (Pd(PPh3)4, CAS: 14221-01-3 (7.26 g, 6.28 mmol) at 15° C. and stirred at 90° C. for 16 h under nitrogen atmosphere. The mixture was poured into water (500 mL) and extracted with EtOAc (2×500 mL). The combined organics were washed with brine, dried and concentrated. The crude was purified by flash column chromatography (hexane/EtOAc=9:1) to give compound III (26 g, 81%) as yellow oil. 1H-NMR (400 MHz, CDCl3): δ=6.97 (dd, J=9.1, 2.1 Hz, 2H), 6.72 (tt, J=8.8, 2.3 Hr, 1H), 5.41 (s, 1H), 2.12 (s, 3H).




embedded image


To a mixture of compound III (20 g, 129 mmol) in acetonitrile (200 mL) was added glyoxylic acid ethyl ester (40 g, 389 mmol) and Yb(OTf)3 (16 g, 25.67 mmol) at 15° C. and stirred at the same temperature for 16 h. The mixture was concentrated, diluted with H2O (200 mL) and extracted with EtOAc (2×200 mL). The combined organics were washed with brine, dried and concentrated. The crude was purified by flash column chromatography (hexane/EtOAc=9:1) to give compound V (14 g, 42%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=6.98-6.92 (m, 2H), 6.74 (tt, J=8.8, 2.3 Hz, 1H), 5.45 (s, 1H), 5.30 (d, J=5.0 Hz, 1H), 4.27 (ddd, J=7.4, 5.9, 4.6 Hz, 1H), 4.22-4.10 (m, 2H), 3.00 (dd, J=14.6, 4.3 Hz, 1H), 2.83-2.73 (m, 2H), 1.28 (t, J=7.1 Hz, 3H).




embedded image


To a mixture of compound V (14 g, 55 mmol) in ethyl vinyl ether (105 mL) was added trifluoroacetic acid (21 mL) at 15° C. and stirred at 50° C. for 16 h. After concentrating the mixture, the crude was purified by flash column chromatography (hexane/EtOAc=10:1) to afford compound VI (12.5 g, 69%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=7.02-6.91 (m, 2H), 6.80-6.69 (m, 1H), 5.44 (d, J=7.3 Hz, 1H), 5.31-5.25 (m, 1H), 4.76-4.84 (m, 1H), 4.32-4.05 (m, 4H), 3.64-3.31 (m, 2H), 2.98-2.78 (m, 2H), 1.31-1.25 (m, 5H), 1.12-1.02 (m, 3H).




embedded image


To a solution of compound VI (12.5 g, 36.6 mmol) in dichloromethane (130 mL) was added triethylamine (7.6 mL, 55 mmol) and trimethylsilyl triflate (8.75 mL, 47.5 mmol) at 0° C. und a nitrogen atmosphere. After stirring for 16 h at room temperature, the mixture was diluted with water (100 mL) and extracted with dichloromethane (2×100 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The residue was purified by flash column chromatography (hexane/EtOAc=10:1) to afford compound VII (7.2 g, 60%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=6.99-6.87 (m, 2H), 6.76-6.71 (m, 1H), 6.34 (dd, J=14.3, 6.8 Hz, 1H), 5.44 (s, 1H), 5.28 (s, 1H), 4.37-4.32 (m, 1H), 4.25-4.13 (m, 3H), 4.07 (dd, J=6.8, 2.5 Hz, 1H), 3.01-2.93 (m, 2H), 1.27 (t, J=7.1 Hz, 3H).




embedded image


To a solution of compound VII (2.0 g, 6.1 mmol) in 1,2-dichloroethane (1 L) was added Grubb's second generation catalyst (CAS: 301224-40-8) (2.0 g, 2.4 mmol) at 0° C. under a nitrogen atmosphere. After stirring for 16 h at 90° C. under nitrogen, the mixture was diluted with water (10 mL) and stirred for 30 min at room temperature. After concentrating the mixture, the residue was purified by flash column chromatography (hexane/EtOAc=10:1) to afford compound VIII (3.0 g, 64%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=6.93 (s, 1H), 6.76-6.69 (m, 2H), 6.65-6.58 (m, 1H), 5.16 (dd, J=11.5, 7.3 Hz, 1H), 4.29 (q, J=7.2 Hz, 2H), 3.34-3.25 (m, 1H), 3.11 (ddd, J=14.8, 7.2, 1.8 Hz, 1H), 1.34 (t, J=7.1 Hz, 3H).


Example 2
Synthesis of 4-(3,5-difluorophenyl)-2-methyl-3H-furan-2-carboxylic acid (Inter B)



embedded image


To a solution of Inter A (2.0 g, 7.9 mmol) in THF (100 mL) was added methyl iodide (5.6 g, 39 mmol) and a solution of lithium bis(trimethylsilyl)amide (1 M in THF, 23.6 mL, 23.6 mmol) at 0° C. under a nitrogen atmosphere. After stirring for 2 h at 0° C. under nitrogen, the mixture was poured into water (50 mL), acidified with aq. HCl (1 M) to pH=3 and extracted with EtOAc (2×100 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The residue was purified by flash column chromatography (hexane/EtOAc=10:1) to afford compound VIII (1.0 g, 47%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=6.87 (t, J=1.8 Hz, 1H), 6.74-6.69 (m, 2H), 6.63-6.59 (m, 1H), 4.31-4.23 (m, 2H), 3.36 (dd, J=14.9, 2.0 Hz, 1H), 2.84 (dd, J=14.9, 2.0 Hz, 1H), 1.68 (s, 3H), 1.33 (t, J=7.2 Hz, 3H).




embedded image


To a solution of compound VIII (0.78 g, 2.9 mmol) in THF (9 mL) was added lithium hydroxide hydrate (367 mg, 8.73 mmol) and water (3 mL). After stirring for 2 h at room temperature, the mixture was diluted with water (10 mL), acidified with aq. HCl (1 M) until pH=3 and extracted with EtOAc (3×10 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated to provide Inter B (1.0 g, quantitative) as a yellow oil. This product was used without further purification in the next step. LC-MS (M+H)+: 240.0.


Example 3
Synthesis of methyl (3S)-3-[[4-(3,5-difluorophenyl)-2-methyl-3H-furan-2-carbonyl]amino]butanoate (Cpd I.1 and Cpd I.2)



embedded image


To a solution of Inter B (0.72 g, 3.0 mmol) in THF (10 mL) was added the HCl salt of amine XI (0.73 g, 4.5 mmol), triethylamine (0.83 mL, 6.0 mmol) and HATU (CAS: 148893-10-1) (1.4 g, 3.6 mmol). After stirring for 2 h at room temperature, the mixture was diluted with water (10 mL) and extracted with methyl tert-butyl ether (3×10 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The residue was purified by prep-HPLC (TFA, to give Cpd I.1 (110 mg, 10%) as yellow oil and Cpd I.2 (100 mg, 10%) as yellow oil (the stereocenter of the diastereomers was not elucidated). Cpd I.1: 1H-NMR (400 MHz, CDCl3): δ=7.12 (br d, J=8.3 Hz, 1H), 6.85 (t, J=1.75 Hz, 1H), 6.75-6.67 (m, 2H), 6.63-6.59 (m, 1H), 4.39-4.29 (m, 1H), 3.64 (s, 3H), 3.31 (dd, J=15.1, 2.0 Hz, 1H), 2.83 (dd, J=15.1, 2.0 Hz, 1H), 2.52 (dd, J=5.5, 2.0 Hz, 2H), 1.64 (s, 3H), 1.27 (d, J=6.6 Hz, 3H). Cpd I.2: 1H-NMR (400 MHz, CDCl3): δ=7.07 (br d, J=8.4 Hz, 1H), 6.87-6.83 (m, 1H), 6.74-6.67 (m, 2H), 6.63-6.59 (m, 1H), 4.39-4.29 (m, 1H), 3.70 (s, 3H), 3.33 (dd, J=15.2, 1.9 Hz, 1H), 2.83 (dd, J=15.2, 1.9 Hz, 1H), 2.56 (dd, J=5.5, 2.7 Hz, 2H), 1.62 (s, 3H), 1.24 (d, J=6.8 Hz, 3H).


Example 4
Synthesis of methyl (1S,4R)-4-[[4-(3,5-difluorophenyl)-2-methyl-3H-furan-2-carbonyl]amino]cyclopent-2-ene-1-carboxylate (Cpd I.5)



embedded image


According to the synthesis of example 3, to a solution of Inter B (2.0 g, 8.3 mmol) in DMF (100 mL) was added the HCl salt of amine X (1.63 g, 9.16 mmol), diisopropylethylamine (4.3 mL, 25 mmol) and HATU (CAS: 148893-10-1) (3.48 g, 9.16 mmol). After stirring for 16 h at room temperature, the mixture was diluted with water (10 mL) and extracted with EtOAc (3×100 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The residue was purified by flash column chromatography (hexane/EtOAc=9:1) to afford Cpd I.5 (1.84 g, 61%) as a 1:1-mixture of diastereomers. 1H-NMR (400 MHz, CDCl3): δ=7.12-7.02 (m, 2H), 6.89-6.85 (m, 1H), 6.84 (t, J=2.0 Hz, 1H), 6.76-6.65 (m, 4H), 6.64-6.55 (m, 2H), 5.97-5.82 (m, 4H), 5.10-5.01 (m, 2H), 3.74 (s, 3H), 3.71 (s, 3H), 3.57-3.50 (m, 2H), 3.35 (dd, J=4.4, 2.0 Hz, 1H), 3.31 (dd, J=4.4, 2.0 Hz, 1H), 2.86 (t, J=2.2 Hz, 1H), 2.82 (t, J=2.1 Hz, 1H), 2.58-2.41 (m, 2H), 1.92 (dt, J=13.9, 3.6 Hz, 1H), 1.85 (dt, J=13.9, 3.5 Hz, 1H), 1.65 (s, 3H), 1.64 (s, 3H).


Example 5
Synthesis of 4-(3,5-dichlorophenyl)-2-methyl-3H-furan-2-carboxylic acid (Inter C)



embedded image


To a solution of compound XI (50 g, 431 mmol) in THF (200 mL) was added propargyl bromide (103 g, 862 mmol) and Zn (64.5 g, 1.08 mol) at room temperature. After heating the reaction to 80° C., the suspension was stirred for 3 h. After cooling to room temperature, the mixture was filtered and the filtrate was quenched with HCl (2N) and extracted with EtOAc. The combined organics were washed with brine, dried over Na2SO4 and concentrated. The crude was purified by flash column chromatography (hexane/EtOAc=100:0 to 7:3) to give the compound XIII (34.6 g, 51.6%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=4.36-4.16 (m, 2H), 2.72-2.50 (m, 2H), 2.06 (t, J=2.57 Hz, 1H), 1.47 (s, 3H), 1.34-1.28 (m, 3H).




embedded image


To a mixture of compound XIII (17 g, 110 mmol) in acetone (300 ml) was added Ag2O (12.6 g, 55 mmol) and triethylamine (11.1 g, 110 mmol) at room temperature. After stirring the reaction at 50° C. for 2 h, the suspension was filtered and the filtrate was concentrated. The crude was purified by flash column chromatography (hexane/EtOAc=100:0 to 1:1) to give the compound XIV (17 g, 100%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=6.30 (q, J=2.4 Hz, 1H), 4.87 (q, J=2.5 Hz, 1H), 4.30-4.18 (m, 2H), 3.04 (dt, J=15.7, 2.3 Hz, 1H) 2.54 (dt, J=15.7, 2.32 Hz, 1H), 1.58 (s, 3H), 1.29-1.33 (t, 3H).




embedded image


To a solution of compound XIV (17 g, 110 mmol) in dichloromethane (250 mL) was added bromine (17.4 g, 110 mmol) in dichloromethane (50 mL) dropwise at −78° C. and stirred at −78° C. for 10 min. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU, CAS: 6674-22-2) (67 g, 440 mmol) was added at −78° C. dropwise. After removing the cold bath, the mixture was stirred for 1 h at room temperature. The mixture was quenched with HCl (1 M) and extracted with dichloromethane (2×50 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The crude was purified by flash column chromatography (hexane/EtOAc=100:0 to 1:1) to give the compound XV (16.5 g, 65%) as a yellow amorphous solid. 1H-NMR (400 MHz, CDCl3): δ=6.37 (t, J=2.1 Hz, 1H), 4.32-4.20 (m, 2H), 3.26 (dd, J=15.3, 2.1 Hz, 1H), 2.74 (dd, J=15.4, 2.2 Hz, 1H), 1.62 (s, 3H), 1.32 (t, J=7.15 Hz, 3H).




embedded image


To the emulsion of compound XV (1.5 g, 6.4 mmol) in a 5:1-mixture of toluene (30 mL) and water (6 mL), aryl boronic acid XVI (1.35 g, 7.05 mmol), Cs2CO3 (10 g, 32 mmol) and Pd(dppf)Cl2 (CAS: 72287-26-4) (300 mg, 0.41 mmol) were added at room temperature and the mixture was stirred at 110° C. for 2 h under nitrogen atmosphere. The reaction was quenched with H2O (20 mL) and extracted with EtOAc (3×30 mL). The combined organics were washed with brine, dried over Na2SO4 and concentrated. The crude was purified by flash column chromatography (hexane/EtOAc=100:0 to 1:1) to provide compound XVII (1.3 g, 68%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=7.14 (t, J=1.6 Hz, 1H), 7.07 (d, J=1.6 Hz, 2H), 6.88 (s, 1H), 4.27 (q, J=7.3 Hz, 2H), 3.36 (dd, J=14.9, 1.9 Hz, 1H), 2.84 (dd, J=14.9, 1.9 Hz, 1H), 1.67 (s, 3H), 1.33 (t, J=7.2 Hz, 3H).




embedded image


To a solution of compound XVII (1.3 g, 4.3 mmol) in a 3:1 mixture of THF (15 mL) and water (5 mL) was added lithium hydroxide (364 mg, 3.34 mmol) at room temperature. After stirring for 2 h, the mixture was quenched with H2O, acidified with aq. HCl (6 M) until pH=3 and extracted with EtOAc (3×20 mL). The combined organics were washed with brine, dried over Na2SO4 and concentrated to give Inter C (900 mg, 77%) as an amorphous yellow solid. The crude was used in the next step without further purification. For analytic purposes a small sample of Inter C was purified by prep-HPLC (TFA, CH3CN—H2O). 1H-NMR (400 MHz, DMSO-d6): δ=13.09 (br s, 1H), 7.44 (s, 1H), 7.35 (d, J=1.6 Hz, 2H), 7.31 (s, 1H), 3.24 (br d, J=13.8 Hz, 1H), 2.85 (br d, J=13.7 Hz, 1H), 1.53 (s, 3H).


Example 6
Synthesis of methyl (3S)-3-[[4-(3,5-dichlorophenyl)-2-methyl-3H-furan-2-carbonyl]amino]butanoate (Cpd I.3 and Cpd I.4)



embedded image


According to the synthesis of example 3, to a solution of Inter C (900 mg, 3.3 mmol) in a mixture of THF (10 mL) and water (2 mL) was added the HCl salt of amine XI (655 mg, 3.97 mmol), triethylamine (667 mL, 6.6 mmol) and HATU (CAS: 148893-10-1) (1.5 g, 4.0 mmol). After stirring for 2 h at room temperature, the mixture was diluted with water (10 mL) and extracted with methyl tert-butyl ether (3×10 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The residue was purified by prep-HPLC (TFA, to give Cpd I.3 (57 mg, 4%) as a yellow oil and Cpd I.4 (57 mg, 4%) as a yellow oil (the stereocenter of the diastereomers was not elucidated). Cpd I.3: 1H-NMR (400 MHz, CDCl3): δ=7.15 (t, J=1.8 Hz, 1H), 7.11 (br d, J=8.6 Hz, 1H), 7.07 (d, J=1.8 Hz, 2H), 6.86 (t, J=1.9 Hz, 1H), 4.40-4.28 (m, 1H), 3.65 (s, 3H), 3.32 (dd, J=15.2, 2.0 Hz, 1H), 2.84 (dd, J=15.2, 2.0 Hz, 1H), 2.53 (dd, J=5.5, 1.3 Hz, 2H), 1.64 (s, 3H), 1.27 (d, J=6.6 Hz, 3H). Cpd I.4: 1H-NMR (400 MHz, CDCl3): δ=7.15 (t, J=1.7 Hz, 1H), 7.08 (d, J=1.7 Hz, 2H), 7.05 (br d, J=8.6 Hz, 1H), 6.86 (s, 1H), 4.41-4.25 (m, 1H), 3.71 (s, 3H), 3.34 (dd, J=15.3, 2.0 Hz, 1H), 2.83 (dd, J=15.2, 2.0 Hz, 1H), 2.65-2.49 (m, 2H), 1.69-1.61 (m, 3H), 1.24 (d, J=6.9 Hz, 3H).


Example 7
Synthesis of 4-(3,5-difluorophenyl)-2-(trifluoromethyl)-3H-furan-2-carboxylic acid (Inter D)



embedded image


According to the synthesis of Inter C, to a solution of compound XVIII (20 g, 13 mmol) in THF (200 mL) was added propargyl bromide (XII) (30.5 g, 256 mmol) and Zn (20.5 g, 321 mmol) at room temperature. After stirring for 2 h, the mixture was filtered, poured into water (100 mL), acidified with HCl (6 M) to pH=3 and extracted with methyl tert-butyl ether (3×100 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The crude was purified by flash column chromatography (hexane/EtOAc=100:0 to 0:100) to give the compound XIX (36 g, 40%) as a yellow oil. The analytical and spectroscopic data are in alignment with the reported data from Tetrahedron 2003, 59, 1389-1394.




embedded image


To a mixture of compound XIX (36 g, 0.18 mol) in acetone (700 ml) was added Ag2O (21.3 g, 91.8 mmol) and triethylamine (25.5 mL, 114 mmol) at room temperature. After stirring the reaction for 2 h in the dark, the suspension was filtered and the filtrate was concentrated. The crude was purified by flash column chromatography (hexane/EtOAc=100:0 to 0:100) to give the compound XX (20 g, 55%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=6.37 (d, J=2.3 Hz, 1H), 5.03 (d, J=2.3 Hz, 1H), 3.89 (s, 3H), 3.13 (d, J=2.4 Hz, 2H).




embedded image


To a solution of compound XX (15 g, 77 mmol) in dichloromethane (200 mL) was added bromine (12 g, 77 mmol) dropwise at −78° C. and stirred at −78° C. for 15 min. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU, CAS: 6674-22-2) (46.5 g, 306 mmol) was added at −78° C. dropwise and stirred for 1 h at the same temperature. The mixture was poured into water (100 mL), acidified with HCl (6 M) to pH=3 and extracted with dichloromethane (2×50 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The crude (8.5 g) was used in the next step without further purification.




embedded image


To the emulsion of compound XXII (7.5 g, 27 mmol) in a 5:1-mixture of toluene (80 mL) and water (16 mL), aryl boronic acid XXIII (4.3 g, 27 mmol), Cs2CO3 (44.9 g, 137 mmol) and Pd(dppf)Cl2 (CAS: 72287-26-4) (1.28 g, 1.75 mmol) were added at room temperature and the mixture was stirred at 110° C. for 1 h under nitrogen atmosphere. The reaction was quenched with H2O (40 mL) and extracted with EtOAc (3×30 mL). The combined organics were washed with brine, dried over Na2SO4 and concentrated. The crude (1.8 g, 7%) was used in the next step without further purification. For analytic purposes a small sample of compound XXIV (55 mg) was purified by prep-HPLC (TFA, CH3CN—H2O). 1H-NMR (400 MHz, CDCl3): δ=6.91 (s, 1H), 6.77-6.72 (m, 2H), 6.68 (tt, J=8.8, 2.1 Hz, 1H), 3.92 (s, 3H), 3.50-3.36 (m, 2H).




embedded image


To a solution of compound XXIV (1.5 g, 4.9 mmol) in a 3:1 mixture of THF (15 mL) and water (5 mL) was added lithium hydroxide (0.31 g, 7.3 mmol) at room temperature. After stirring for 2 h, the mixture was quenched with H2O, acidified with aq. HCl (6 M) until pH=3 and extracted with EtOAc (3×20 mL). The combined organics were washed with brine, dried over Na2SO4 and concentrated to give Inter C (900 mg, 77%) as an amorphous yellow solid. The crude (1.5 g, 21%) was used in the next step without further purification. For analytic purposes a small sample of Inter D was purified by prep-HPLC (TFA, CH3CN—H2O). 1H-NMR (400 MHz, CDCl3): δ=7.59 (s, 1H), 7.16 (br dd, J=9.3, 2.2 Hz, 2H), 7.05 (tt, J=9.3, 2.1 Hz, 1H), 3.45 (d, J=1.8 Hz, 2H).


Example 8
Synthesis of methyl (3S)-3-[[4-(3,5-difluorophenyl)-2-(trifluoromethyl)-3H-furan-2-carbonyl]amino]butanoate (Cpd I.7)



embedded image


According to the synthesis of example 3, to a solution of Inter D (800 mg, 2.7 mmol) in THF (10 mL) was added the HCl salt of amine IX (642 mg, 5.44 mmol), triethylamine (0.76 mL, 5.4 mmol) and HATU (CAS: 148893-10-1) (1.55 g, 4.08 mmol). After stirring for 2 h at room temperature, the mixture was diluted with water (10 mL), acidified to pH=3 with aq. HCl (2 N) and extracted with EtOAc (3×10 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The residue was purified by prep-HPLC (TFA, to give Cpd I.7 (180 mg, 17%) as a 1:1 mixture of diastereomers. 1H-NMR (400 MHz, CDCl3): δ=7.44-7.28 (m, 2H), 6.89 (s, 2H), 6.79-6.73 (m, 4H), 6.71-6.6.68 (m, 2H), 4.45-4.33 (m, 2H), 3.71 (s, 3H), 3.68 (s, 3H), 3.57-3.47 (m, 2H), 3.40-3.31 (m, 2H), 2.62-2.53 (m, 4H), 1.32-I.26 (m, 6H).


Example 9
Synthesis of ethyl 4-(3,5-difluorophenyl)-1-methyl-2-oxo-cyclopent-3-ene-1-carboxylate (Inter E)



embedded image


Following the reported experimental procedure described in Org. Lett. 2006, 8, 1419-1422, to a mixture of compound diethyl 2-methylpropanedioate (XXVII) (4.5 g, 26 mmol) in toluene (60 mL) was added NaH (1.0 g, 26 mmol) at 0° C. and the suspension stirred at 15° C. for 1 h. The mixture was added to a solution of 1,3-difluoro-5-iodo-benzene (XXV) (3.0 g, 13 mmol), compound 2-allenyl-4,4,5,5-tetramethyl-(1,3,2)-dioxaborolane (XXVI, CAS: 865350-17-0) (4.26 g, 25.6 mmol), Pd2(dba)3 (300 mg, 0.425 mmol) and P(C6H4CF3-4)3 (600 mg, 1.3 mmol) at 15° C. and stirred at 80° C. for 16 h under nitrogen atmosphere. The mixture was filtered through ca. 2 cm plug of silica gel, rinsed with toluene and the combined filtrates were concentrated. The residue was purified by flash column chromatography (hexane/EtOAc=9:1) and the combined mixed fractions were repurified by prep-HPLC (NH4HCO3—H2O-MeCN) to give compound XXVIII (1 g, 17%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=6.83 (dd, J=8.5, 1.9 Hz, 2H), 6.69-6.60 (m, 1H), 5.67 (s, 1H), 4.27-4.15 (m, 4H), 3.96-3.76 (m, 2H), 1.42 (s, 3H), 1.31-I.24 (m, 12H), 1.15 (t, J=7.1 Hz, 6H).




embedded image


Following the reported experimental procedure described in Org. Lett. 2006, 8, 1419-1422, to a solution of alkenyl boronate XXVII (300 mg, 0.77 mmol) in 1,4-dioxane (8 ml) was added 1,4-bis(diphenylphosphino)-butane (dppb, CAS: 7688-25-7) (165 mg, 0.386 mmol), Cs2CO3 (753 mg, 2.31 mmol), H2O (42 mg, 2.31 mmol) and bis-(1,5-cyclooctadiene)-dirhodium(I)-dichloride ([RhCl(cod)]2, CAS: 12092-47-6) (95 mg, 0.19 mmol) at 15° C. and stirred at 95° C. for 4 h. The mixture was filtered and concentrated. The crude was purified by prep-HPLC (TFA-H2O-MeCN) to afford Inter E (100 mg, 46.38%) as a white amorphous solid. 1H-NMR (400 MHz, CDCl3): δ=7.17 (dd, J=8.03, 2.1 Hz, 2H), 6.96 (tt, J=8.6, 2.2 Hz, 1H), 6.54-6.50 (m, 1H), 4.19 (qd, J=7.1, 3.2 Hz, 2H), 3.58 (dd, J=17.9, 1.8 Hz, 1H), 2.83 (dd, J=17.9, 1.63 Hz, 1H), 1.51 (s, 3H), 1.25 (t, J=7.15 Hz, 3H).


Example 10
Synthesis of 3-(3,5-difluorophenyl)-1-methyl-2-oxo-cyclopent-3-ene-1-carboxylic acid (Inter F)



embedded image


To a mixture of compound ethyl 2-oxocyclopentanecarboxylate (XXIX) (10 g, 64 mmol) in acetonitrile (100 ml) was added K2CO3 (26.5 g, 190 mmol) and methyl iodide (18 g, 0.13 mmol) at 15° C. The mixture was stirred at 40° C. for 16 h. After filtration of the suspension, the filtrate was concentrated. The residue was purified by flash column chromatography (EtOAc/hexane=0:100 to 100:0) to give the compound ethyl 1-methyl-2-oxo-cyclopentanecarboxylate (XXX) (10 g, 92%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=4.23-4.10 (m, 2H), 2.57-2.24 (m, 3H), 2.12-1.80 (m, 3H), 1.31 (s, 3H), 1.25 (t, J=7.1 Hz, 3H).




embedded image


To a mixture of compound XXX (5.0 g, 29 mmol) in DMSO (150 ml) was added 2-iodoxybenzoic acid (IBX, CAS: 61717-82-6) (24.7 g, 88 mmol) at 15° C. The mixture was stirred at 80° C. for 16 h. After filtration of the suspension, the filtrated was quenched with aq. sat. NaHCO3 (100 mL) and extracted with EtOAc. The combined organics were washed with brine, dried over Na2SO4 and concentrated. The crude was purified by flash column chromatography (EtOAc/hexane=0:100 to 100:0) to give the compound ethyl 1-methyl-2-oxo-cyclopent-3-ene-1-carboxylate (XXXI) (3.8 g, 78%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=7.75 (td, J=2.8, 5.6 Hz, 1H), 6.19 (dt, J=5.7, 2.2 Hz, 1H), 4.20-4.10 (m, 2H), 3.26 (dt, J=19.1, 2.4 Hz, 1H), 2.55 (dt, J=19.2, 2.3 Hz, 1H), 1.41 (s, 3H), 1.27-1.19 (m, 3H).




embedded image


To a mixture of compound XXXI (3.4 g, 20 mmol) in dichloromethane (20 mL) was added bromine (3.2 g, 20 mmol) dropwise at 0° C. After stirring for 15 min at the same temperature, triethylamine (4.08 g, 40.4 mmol) was added. After stirring for 15 min at room temperature, the mixture was quenched with sat. sodium thiosulfate (20 mL) and extracted with dichloromethane (3×20 mL). The combined organics were washed with brine, dried over Na2SO4 and concentrated to give the compound ethyl 3-bromo-1-methyl-2-oxo-cyclopent-3-ene-1-carboxylate (XXXII) (4.5 g, 90%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ=7.80 (t, J=3.0 Hz, 1H), 4.22-4.13 (m, 2H), 3.22 (dd, J=18.9, 3.1 Hz, 1H), 2.53 (dd, J=19.0, 3.0 Hz, 1H), 1.46 (s, 3H), 1.24 (t, J=7.0 Hz, 3H).




embedded image


In analogy to the synthesis of Inter C in example 5, the mixture containing of compound XXXII (1.5 g, 6.0 mmol), aryl boronic acid XXIII (1.7 g, 9.1 mmol), Cs2CO3 (5.8 g, 18 mmol) and Pd(dppf)Cl2 (150 mg) in a 5:1 mixture of toluene (15 mL) and water (3 mL) was stirred at 100° C. under a nitrogen atmosphere for 0.5 h. The reaction was quenched with H2O and extracted with EtOAc. The combined organics were washed with brine. Dried and concentrated. The crude was purified by prep-HPLC (TFA, CH3CN—H2O) to afford ethyl 3-(3,5-difluorophenyl)-1-methyl-2-oxo-cyclopent-3-ene-1-carboxylate (XXXIII) (900 mg, 48%) as a yellow amorphous solid. 1H-NMR (400 MHz, CDCl3): δ=7.92 (t, J=3.0 Hz, 1H), 7.66 (d, J=1.9 Hz, 2H), 7.35 (t, J=1.8 Hz, 1H), 4.18 (q, J=7.2 Hz, 2H), 3.30 (dd, J=19.8, 3.0 Hz, 1H), 2.60 (dd, J=19.7, 3.0 Hz, 1H), 1.49 (s, 3H), 1.24 (t, J=7.2 Hz, 3H).




embedded image


According to the general procedure for saponification, to a solution of compound XXXIII (553 mg, 1.90 mmol) in a 1:1 mixture of THF (3 mL) and water (3 mL) was added lithium hydroxide (91 mg, 3.8 mmol) at room temperature. After stirring for 2 h, the mixture was quenched with H2O, acidified with aq. HCl (2 M) until pH=3 and extracted with EtOAc (3×20 mL). The combined organics were washed with brine, dried over Na2SO4 and concentrated to give Inter F (900 mg, 77%) as an amorphous yellow solid. The crude (200 mg, 42%) was used in the next step without further purification.


Example 11
Synthesis of methyl (1S,4R)-4-[[3-(3,5-difluorophenyl)-1-methyl-2-oxo-cyclopent-3-ene-1-carbonyl]amino]cyclopent-2-ene-1-carboxylate (Cpd 111.1)



embedded image


According to the general procedure for HATU-mediated amide coupling (see example 4), to a solution of Inter F (23.6 mg, 9.36 μmol) in DMF (4 mL) was added the HCl salt of amine X (16.6 mg, 9.36 μmol), diisopropylethylamine (0.048 mL, 0.28 mmol) and HATU (CAS: 148893-10-1) (49 mg, 0.12 mmol). After stirring for 16 h at room temperature, the mixture was diluted with water (5 mL) and extracted with EtOAc (3×10 mL). The combined extracts were washed with brine, dried over Na2SO4 and concentrated. The residue was purified by flash column chromatography (hexane/EtOAc=9:1) to afford Cpd 111.1 (20 mg, 57%) as a 1:1-mixture of diastereomers. 1H-NMR (400 MHz, CDCl3): δ=7.93 (t, J=3.0 Hz, 2H), 7.37-7.24 (m, 4H), 7.21 (s, 2H), 6.84-6.72 (m, 2H), 6.05-5.73 (m, 4H), 5.06-5.01 (m, 2H), 3.78 (s, 3H), 3.76 (s, 3H), 3.72-3.67 (m, 1H), 3.64 (dd, J=3.1, 1.5 Hz, 1H), 3.58-3.47 (m, 2H), 2.66-2.40 (m, 4H), 1.96 (dt, J=13.9, 3.7 Hz, 1H), 1.86 (dt, J=13.9, 3.9 Hz, 1H), 1.53 (s, 3H), 1.51 (s, 3H).


Example 12
Synthesis of methyl 4-[(1-methyl-3-phenyl-cyclopent-3-ene-1-carbonyl)amino]cyclopent-2-ene-1-carboxylate (Cpd IV2)



embedded image


According to the general procedure for HATU-mediated amide coupling (see example 4), to a solution of literature-known, Angew. Chem. Int. Ed. 2018, 57, 2721-2725., carboxylic acid XXXIV (35 mg, 0.17 mmol) in DMF was added the HCl salt of amine X (30 mg, 0.17 mmol), diisopropylethylamine (0.76 mL, 0.52 mmol) and HATU (CAS: 148893-10-1) (83 mg, 0.21 mmol). After stirring for 18 h at room temperature, the mixture was concentrated and the residue was purified by prep-HPLC (water/acetonitrile) to afford Cpd IV.2 (39 mg, 69%) as a 1:1-mixture of diastereomers. 1H-NMR (400 MHz, CDCl3): δ=7.46-7.39 (m, 2H), 7.29-7.20 (m, 2H), 7.19-7.12 (m, 1H), 6.79-6.74 (m, 1H), 6.07-6.03 (m, 1H), 5.90-5.74 (m, 3H), 5.07-4.94 (m, 1H), 3.66-3.61 (m, 3H), 3.52-3.47 (m, 1H), 3.30-3.22 (m, 1H), 3.10-3.00 (m, 1H), 2.55-2.47 (m, 1H), 2.36-2.28 (m, 1H), 1.85-1.75 (m, 1H), 1.32-1.29 (m, 3H).


High Performance Liquid Chromatography: HPLC-column Kinetex XB C18 1.7μ (50×2.1 mm); eluent: acetonitrile/water+0.1% trifluoroacetic acid (gradient from 5:95 to 100:0 in 1.5 min at 60° C., flow gradient from 0.8 to 1.0 ml/min in 1.5 min).


In analogy to the examples described above, the following compounds of formula (I), wherein W1 is —O—, W2 is —CH2— and R1, R8 are hydrogen, were prepared using commercially available amines:









TABLE 2









embedded image




















Cpd.
R2
R3
R4
R5
R6
R7
N*—X—Y
HPLC/MS





I1#
H
F
H
F
H
(R)-CH3


embedded image


340.1





I2#
H
F
H
F
H
(S)-CH3


embedded image


340.1





I3#
H
Cl
H
Cl
H
(R)-CH3


embedded image


372.1





I4#
H
Cl
H
Cl
H
(S)-CH3


embedded image


372.1





I5
H
F
H
F
H
CH3


embedded image


364.3





I6
H
Cl
H
Cl
H
CH3


embedded image


395.7





I7
H
F
H
F
H
CF3


embedded image


394.1





I8
H
F
H
F
H
CF3


embedded image


418.2





I9
H
F
H
F
H
CH3


embedded image


368.2





I10
H
F
H
F
H
CH3


embedded image


366.3





I11
H
F
H
F
H
CH3


embedded image


352.3





I12
H
F
H
F
H
CH3


embedded image


354.2





I13
H
F
H
F
H
CH3


embedded image


354.2





I14
H
Cl
H
Cl
H
CH3


embedded image


398.2





I15
H
F
H
F
H
CF3


embedded image


405.9





I16
H
F
H
F
H
CH3


embedded image


359.9





I17
H
F
H
F
H
CH3


embedded image


433.9





I18#
H
F
H
F
H
(R)-CH3


embedded image


395.7





I19#
H
F
H
F
H
(S)-CH3


embedded image


395.7





#: compounds I1-I4, I18-19 are single isomers, prepared from enantiopure (S)- or (R)-


Inter B and C.




embedded image

HPLC/MS = MassChargeRatio







In analogy to the examples described above, the following compounds of formula (I), wherein W1 is —C(O)—, W2 is —CH2— and R1, R8 are hydrogen, were prepared using commercially available amines:




embedded image

















TABLE 3





Cpd.
R2
R3
R4
R5
R6
R7
N*—X—Y
HPLC/MS







II1
H
F
H
F
H
CH3


embedded image


n.d.







embedded image

HPLC/MS = MassChargeRatio







In analogy to the examples described above, the following compounds of formula (I), wherein W1 is —CH2—, W2 is —C(O)— and R1, R8 are hydrogen, were prepared using commercially available amines:




embedded image

















TABLE 4













HPLC/


Cpd.
R2
R3
R4
R5
R6
R7
N*—X—Y
MS







III1
H
F
H
F
H
CH3


embedded image


375.9





III2
H
F
H
F
H
CH3


embedded image


351.9





III3
H
F
H
F
H
CH3


embedded image


365.9







embedded image

HPLC/MS = MassChargeRatio







In analogy to the examples described above, the following compounds of formula (I), wherein W1 is —CH2—, W2 is —CH2— and R1, R8 are hydrogen, were prepared using commercially available amines:




embedded image

















TABLE 5













HPLC/


Cpd.
R2
R3
R4
R5
R6
R7
N*—X—Y
MS







IV1
H
H
H
H
H
H


embedded image


312.2





IV2
H
H
H
H
H
CH3


embedded image


326.2







embedded image

HPLC/MS = MassChargeRatio







B USE EXAMPLES

The herbicidal activity of the compounds of formula (I) was demonstrated by the following greenhouse experiments:


The culture containers used were plastic flowerpots containing loamy sand with approximately 3.0% of humus as the substrate. The seeds of the test plants were sown separately for each species.


For the pre-emergence treatment, the active ingredients, which had been suspended or emulsified in water, were applied directly after sowing by means of finely distributing nozzles. The containers were irrigated gently to promote germination and growth and subsequently covered with transparent plastic hoods until the test plants had rooted. This cover caused uniform germination of the test plants, unless this had been impaired by the active ingredients. For the post-emergence treatment, the test plants were first grown to a height of 3 to 15 cm, depending on the plant habit, and only then treated with the active ingredients which had been suspended or emulsified in water. For this purpose, the test plants were either sown directly and grown in the same containers, or they were first grown separately as seedlings and transplanted into the test containers a few days prior to treatment.


Depending on the species, the test plants were kept at 10-25° C. or 20-35° C., respectively. The test period extended over 2 to 4 weeks. During this time, the test plants were tended, and their response to the individual treatments was evaluated.


Evaluation was carried out using a scale from 0 to 100. 100 means no emergence of the test plants, or complete destruction of at least the aerial moieties, and 0 means no damage, or normal course of growth. A good herbicidal activity is given at values of 60 to 90 and a very good herbicidal activity is given at values of 90 to 100.


The test plants used in the greenhouse experiments were of the following species:
















Bayer code
Scientific name









ABUTH

Abutilon theophrasti




ALOMY

Alopercurus myosuroides




AMARE

Amaranthus retroflexus




APESV

Apera spica-venti




AVEFA

Avena fatua




ECHCG

Echinocloa crus-galli




SETVI

Setaria viridis




SETFA

Setaria faberi




LOLMU

Lolium multiflorum











At an application rate of 1,000 kg/ha, applied by the pre-emergence method:

    • compounds I1, I2, I3 showed very good herbicidal activity against APESV.
    • compounds I1, I3 showed very good herbicidal activity against ECHCG.
    • compound I2 showed good herbicidal activity against ECHCG.
    • compounds I1, I3 showed very good herbicidal activity against SETFA.
    • compound I2 showed good herbicidal activity against SETFA.


At an application rate of 0.250 kg/ha, applied by the pre-emergence method:

    • compounds I5, I7, I8, I10, I11, I12, I15 showed very good herbicidal activity against APESV.
    • compounds I9, I14 showed good herbicidal activity against APESV.
    • compounds I5, I15 showed very good herbicidal activity against ECHCG.
    • compounds I6, I7, I10, I11, I12 showed good herbicidal activity against ECHCG.
    • compounds I5, I6, I18 showed very good herbicidal activity against AMARE.
    • compounds I8 showed good herbicidal activity against AMARE.
    • compounds I7, I8, I11, I15 showed very good herbicidal activity against SEFTA.
    • compound I112 showed good herbicidal activity against SEFTA.
    • compound I18 showed very good herbicidal activity against SETVI.
    • compound I18 showed very good herbicidal activity against LOLMU.


At an application rate of 0.125 kg/ha, applied by the pre-emergence method:

    • compound I113 showed good herbicidal activity against APESV.
    • compound I113 showed good herbicidal activity against ABUTH.
    • compound I113 showed good herbicidal activity against AMARE.


At an application rate of 1.000 kg/ha, applied by the post-emergence method:

    • compound I1 showed very good herbicidal activity against ALOMY.
    • compound I2 showed good herbicidal activity against ALOMY.
    • compound I2, I4 showed very good herbicidal activity against AVEFA.
    • compound I3 showed very good herbicidal activity against AMARE.
    • compounds I1, I3 showed very good herbicidal activity against ECHCG.
    • compounds I1, I2, I3, I4 showed very good herbicidal activity against SETVI.


At an application rate of 0.250 kg/ha, applied by the post-emergence method:

    • compounds I5, I6, I8, I9, I10, I11, I12, I15, I16, I17, I18 showed very good herbicidal activity against AMARE.
    • compound I14 showed good herbicidal activity against AMARE.
    • compounds I5, I6, I7, I8, I11, I12, I15, I16, I17, I18 showed very good herbicidal activity against ECHCG.
    • compound I111 showed good herbicidal activity against ECHCG.
    • compounds I5, I7, I9, I10, I11, I12, I15, I16, I17, I18 showed very good herbicidal activity against AVEFA.
    • compounds I13, I19 showed good herbicidal activity against AVEFA.
    • compound I6 showed very good herbicidal activity against ALOMY
    • compounds I7, I8, I19 showed good herbicidal activity against ALOMY.
    • compound I14 showed good herbicidal activity against ABUTH.
    • compounds I9, I10 showed very good herbicidal activity against SETVI.


At an application rate of 0.125 kg/ha, applied by the post-emergence method:

    • compound I113 showed very good herbicidal activity against ABUTH.

Claims
  • 1. A compound of formula (I)
  • 2. The compound as claimed in claim 1, wherein the substituents have the following meaning: W1 —CH2—, —C(O)—, or —O—;W2 —CR9R10— or —C(O)—.
  • 3. The compound as claimed in claim 1, wherein the substituents have the following meaning: R1 hydrogen.
  • 4. The compound as claimed in claim 1, wherein the substituents have the following meaning: R2 hydrogen, halogen, (C1-C3)-alkyl;R6 hydrogen, halogen, (C1-C3)-alkyl.
  • 5. The compound as claimed in claim 1, wherein the substituents have the following meaning: R3 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl;R5 hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl.
  • 6. The compound as claimed in claim 1, wherein the substituents have the following meaning: R4 hydrogen, halogen.
  • 7. The compound as claimed in claim 1, wherein the substituents have the following meaning: R7 (C1-C2)-alkyl, cyclopropyl, (C1-C2)-haloalkyl, (C2-C3)-alkenyl, (C1-C2)-alkoxy;R3 hydrogen or halogen.
  • 8. The compound as claimed in claim 1, wherein the substituents have the following meaning: R9 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl;R10 hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl.
  • 9. The compound as claimed in claim 1, wherein the substituents have the following meaning: X a bond.
  • 10. The compound as claimed in claim 1, wherein the substituents have the following meaning: X a bond;Y (C1-C8)-alkyl, (C3-C8)-cycloalkyl, (C2-C8)-alkenyl or (C2-C8)-alkynyl, each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, ORd, Z, OZ, NHZ, S(O)nRa, SO2NRbRd, SO2NRbCORe, CO2Re, CONRbRh, CORb, CONReSO2Ra, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re NRbSO2NRbRe, OCONRbRe, OCSNRbRe, PORfRf, and C(Rb)═NORe.
  • 11. The compound as claimed in claim 1, wherein the substituents have the following meaning: X a bond;Y Z;Z a four- or five-membered saturated or partly unsaturated ring, which is formed from r carbon atoms and n oxygen atoms, each substituted by selected m radicals from the group consisting of CO2Re, CONRbRh, Rb, Rc, Re, and Rf.
  • 12. A composition comprising at least one compound as claimed in claim 1, and at least one auxiliary, which is customary for formulating crop protection compounds.
  • 13. The composition as claimed in claim 12, comprising a further herbicide.
  • 14. (canceled)
  • 15. A method for controlling unwanted vegetation which comprises contacting a herbicidally effective amount of at least one compound as claimed in claim 1 with plants, their seed, and/or their habitat.
Priority Claims (1)
Number Date Country Kind
21181068.4 Jun 2021 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2022/066065 6/14/2022 WO